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Materials and Methods  
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage 
through an activated alumina column under argon.1 Reaction progress was monitored by thin-
layer chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was performed using E. Merck 
silica gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence 
quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic Silica gel 
(particle size 40–63 nm) was used for flash chromatography.  1H NMR spectra were recorded on 
Varian Inova 500 MHz and Bruker 400 MHz spectrometers and are reported relative to residual 
CHCl3 (δ 7.26 ppm).  13C NMR spectra were recorded on a Varian Inova 500 MHz spectrometer 
(125 MHz) and Bruker 400 MHz spectrometers (100 MHz) and are reported relative to CHCl3 
(δ 77.16 ppm). Data for 1H NMR are reported as follows: chemical shift (δ ppm) (multiplicity, 
coupling constant (Hz), integration).  Multiplicities are reported as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet, br 
d = broad doublet.  Data for 13C NMR are reported in terms of chemical shifts (δ ppm).  IR 
spectra were obtained by use of a Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 
FTIR spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm–1).  Optical rotations were measured with a Jasco P-2000 polarimeter operating 
on the sodium D-line (589 nm), using a 100 mm path-length cell.  Analytical SFC was performed 
with a Mettler SFC supercritical CO2 analytical chromatography system utilizing Chiralpak (AD-
H, AS-H or IC) or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from 
Daicel Chemical Industries, Ltd. High resolution mass spectra (HRMS) were obtained from 
Agilent 6200 Series TOF with an Agilent G1978A Multimode source in electrospray ionization 
(ESI+), atmospheric pressure chemical ionization (APCI+), or mixed ionization mode (MM: 
ESI-APCI+).  Absolute configuration of 2d was determined by X-ray diffraction, and all other 
products are assigned by analogy.   
Reagents were purchased from commercial sources and used as received unless otherwise 
stated.  Ligand L1 was prepared according to literature procedure.2  
List of Abbreviations: 
ee – enantiomeric excess, SFC – supercritical fluid chromatography, TLC – thin-layer 
chromatography, IPA – isopropanol 
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General Procedure for Pd-Catalyzed Allylic Alkylation Reactions 
 
In a nitrogen-filled glovebox, a solution of Pd2(dba)3 (1.8 mg/mL) and (S)-Ty-PHOX (2.8 
mg/mL) in toluene was stirred for 30 min at 25 °C, then 0.5 mL of the resulting catalyst solution 
was added to a one dram vial containing allyl enol carbonate substrate (0.2 mmol) dissolved in 
hexane (1.5 mL).  The vial was sealed with a Teflon-lined cap, removed from the glovebox, and 
stirred at 25 °C for 12 h unless noted otherwise.  The crude reaction mixture was concentrated 
then purified by silica gel flash chromatography to provide the desired alkylation product. 
 
  
 (R)-2-ethyl-1-(1H-indol-1-yl)-2-phenylpent-4-en-1-one (2a) 
Purified by column chromatography (5% Et2O in hexanes) to provide an amorphous white solid 
(64.8 mg, 99% yield); 95% ee, [α]D25 –111.4 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.58 
(dt, J = 8.3, 0.8 Hz, 1H), 7.48–7.44 (m, 1H), 7.39–7.32 (m, 3H), 7.32–7.22 (m, 4H), 6.84 (d, J = 
3.9 Hz, 1H), 6.26 (d, J = 3.8 Hz, 1H), 5.45 (dddd, J = 16.6, 10.2, 8.5, 6.2 Hz, 1H), 5.03–4.92 (m, 
2H), 2.99 (dd, J = 14.0, 8.5 Hz, 1H), 2.88 (dd, J = 14.0, 6.2 Hz, 1H), 2.25 (qd, J = 7.4, 1.5 Hz, 
2H), 0.81 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 174.3, 143.0, 136.5, 133.0, 129.5, 
129.2, 127.3, 126.5, 126.1, 125.1, 123.7, 120.6, 119.0, 117.2, 108.2, 56.8, 40.5, 28.0, 8.4.; IR 
(Neat Film, NaCl) 3154, 3071, 2974, 2880, 1694, 1643, 1600, 1584, 1538, 1495, 1471, 1463, 
1446, 1380, 1303, 1206, 1225, 1149, 1077, 1019, 1000, 920, 891, 820, 767, 701 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C21H22NO [M+H]+: 304.1696, found 304.1691; SFC 
Pd2dba3 (0.5 mol %)
ligand (1.2 mol %)
hexane/toluene (3:1)
25 °C, 10 h
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Conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 
6.41, major = 6.95.  
 
 
 
 
(R)-2-allyl-1-(1H-indol-1-yl)-2-phenylheptan-1-one (2b) 
Purified by column chromatography (5% Et2O in hexanes) to provide an amorphous white solid 
(68.4 mg, 99% yield); 96% ee, [α]D25 –81.8 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.58 
(dq, J = 8.4, 0.8 Hz, 1H), 7.46 (dt, J = 7.6, 1.1 Hz, 1H), 7.35 (ddt, J = 8.3, 5.3, 1.7 Hz, 3H), 7.30–
7.22 (m, 4H), 6.85 (d, J = 3.9 Hz, 1H), 6.26 (dd, J = 3.8, 0.7 Hz, 1H), 5.44 (dddd, J = 16.6, 10.1, 
8.5, 6.1 Hz, 1H), 5.03–4.90 (m, 2H), 3.00 (dd, J = 14.0, 8.6 Hz, 1H), 2.88 (dd, J = 14.0, 6.1 Hz, 
1H), 2.25–2.11 (m, 2H), 1.35–1.24 (m, 1H), 1.21 (qd, J = 6.5, 6.0, 3.1 Hz, 4H), 1.10–0.98 (m, 
1H), 0.81–0.75 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 174.4, 143.2, 136.5, 133.2, 129.5, 129.2, 
127.3, 126.4, 126.1, 125.1, 123.7, 120.6, 119.0, 117.3, 108.2, 56.4, 41.3, 35.0, 32.2, 23.4, 22.4, 
14.0; IR (Neat Film, NaCl) 3071, 2954, 2928, 2859, 1696, 1449, 1304, 1204, 1078, 919, 750, 
702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C24H28NO [M+H]+: 346.2165, found 
N
O
n-Pentyl
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346.2156; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR 
(min): minor = 4.87, major = 5.84.  
 
 
 
 
(R)-1-(1H-indol-1-yl)-2-isobutyl-2-phenylpent-4-en-1-one (2c) 
Purified by column chromatography (5% Et2O in hexanes) to provide an amorphous white solid 
(66.1 mg, 99% yield); 96% ee, [α]D25 –109.1 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
8.62–8.52 (m, 1H), 7.49–7.43 (m, 1H), 7.39–7.32 (m, 3H), 7.30–7.21 (m, 4H), 6.87 (d, J = 3.8 
Hz, 1H), 6.27 (d, J = 3.8 Hz, 1H), 5.42 (dddd, J = 16.5, 9.9, 8.7, 5.9 Hz, 1H), 5.04–4.89 (m, 2H), 
3.13–3.01 (m, 1H), 2.91 (ddd, J = 14.2, 5.9, 1.5 Hz, 1H), 2.26 (dd, J = 14.1, 4.4 Hz, 1H), 2.10 
(ddd, J = 14.1, 6.5, 1.1 Hz, 1H), 1.74 (ddt, J = 13.2, 11.0, 6.5 Hz, 1H), 0.84 (d, J = 6.6 Hz, 3H), 
0.62 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 174.8, 143.3, 136.5, 133.3, 129.6, 
129.2, 127.3, 126.4, 126.1, 125.2, 123.8, 120.6, 119.2, 117.3, 108.2, 56.1, 43.5, 42.2, 25.2, 24.1, 
23.5; IR (Neat Film, NaCl) 3164, 3071, 3026, 2957, 2868, 1693, 1639, 1600, 1584, 1537, 1472, 
1449, 1306, 1222, 1206, 1149, 1079, 919, 890, 767, 750, 702 cm–1; HRMS (MM:ESI-APCI+) 
m/z calc’d for C23H26NO [M+H]+: 332.2009, found 332.1998; SFC Conditions: 10% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 4.86, major = 5.20.  
N
O
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(S)-2-benzyl-1-(1H-indol-1-yl)-2-phenylpent-4-en-1-one (2d) 
Purified by column chromatography (5% Et2O in hexanes) to provide an amorphous white solid 
(70.5 mg, 96% yield); 90% ee, [α]D25 +50.9 (c 0.65, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
8.54–8.50 (m, 1H), 7.48 (dt, J = 7.8, 1.0 Hz, 1H), 7.38–7.29 (m, 4H), 7.29–7.23 (m, 1H), 7.18–
7.11 (m, 3H), 7.06 (dd, J = 8.2, 6.9 Hz, 2H), 6.92 (d, J = 3.8 Hz, 1H), 6.60 (dd, J = 7.6, 1.5 Hz, 
2H), 6.32 (d, J = 3.9 Hz, 1H), 5.82–5.69 (m, 1H), 5.11–5.05 (m, 1H), 5.00–4.93 (m, 1H), 3.56 (d, 
J = 13.5 Hz, 1H), 3.42 (d, J = 13.5 Hz, 1H), 2.89 (d, J = 7.1 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 173.7, 142.4, 136.6, 136.3, 132.8, 130.8, 129.5, 129.1, 127.8, 127.6, 126.8, 126.7, 
126.0, 125.2, 123.8, 120.6, 119.8, 117.3, 108.5, 57.8, 42.4, 39.0; IR (Neat Film, NaCl) 3062, 
3028, 2926, 1694, 1601, 1584, 1537, 1495, 1449, 1328, 1305, 1203, 1078, 1019, 894, 751, 720, 
702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C26H24NO [M+H]+: 366.1852, found 
366.1855; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 235 nm, tR 
(min): minor = 17.49, major = 18.37. 
N
O
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(R)-2-ethyl-1-(1H-indol-1-yl)-2-(p-tolyl)pent-4-en-1-one (2e) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (62.9 mg, 
99% yield); 98% ee, [α]D25 –112.1 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.57 (dq, J = 
8.4, 1.0 Hz, 1H), 7.46 (d, J = 7.6 Hz, 1H), 7.35 (ddt, J = 8.4, 7.1, 1.3 Hz, 1H), 7.26–7.21 (m, 
1H), 7.15 (d, J = 1.0 Hz, 4H), 6.88 (dd, J = 3.9, 1.2 Hz, 1H), 6.27 (d, J = 3.8 Hz, 1H), 5.44 
(dddd, J = 17.6, 10.9, 9.3, 6.6 Hz, 1H), 5.03–4.91 (m, 2H), 3.00–2.81 (m, 2H), 2.35 (s, 3H), 2.22 
(q, J = 7.4 Hz, 2H), 0.80 (td, J = 7.4, 1.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 174.5, 139.9, 
137.0, 136.5, 133.2, 129.9, 129.5, 126.3, 126.3, 125.0, 123.7, 120.5, 118.9, 117.2, 108.1, 56.4, 
40.5, 28.0, 21.2, 8.4; IR (Neat Film, NaCl) 2973, 1695, 1640, 1585, 1537, 1514, 1472, 1450, 
1380, 1321, 1304, 1224, 1206, 1105, 1077, 1020, 918, 893, 813, 768, 750 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C22H24NO [M+H]+: 318.1852, found 318.1848; SFC 
Conditions: 15% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 
4.21, major = 4.75. 
N
O
Et
Me
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(R)-2-ethyl-1-(1H-indol-1-yl)-2-(4-methoxyphenyl)pent-4-en-1-one (2f) 
Purified by column chromatography (10% Et2O in hexanes) to provide an amorphous white solid 
(59.2mg, 89% yield); 98% ee, [α]D25 –118.8 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.58 
(dq, J = 8.3, 0.8 Hz, 1H), 7.47 (ddd, J = 7.7, 1.4, 0.7 Hz, 1H), 7.35 (ddd, J = 8.3, 7.1, 1.3 Hz, 
1H), 7.30–7.21 (m, 1H), 7.21–7.15 (m, 2H), 6.93–6.85 (m, 3H), 6.28 (dd, J = 3.9, 0.7 Hz, 1H), 
5.45 (dddd, J = 16.6, 10.2, 8.5, 6.1 Hz, 1H), 5.04–4.90 (m, 2H), 3.81 (s, 3H), 2.96 (dd, J = 13.9, 
8.5 Hz, 1H), 2.85 (dd, J = 14.0, 6.1 Hz, 1H), 2.21 (q, J = 7.4 Hz, 2H), 0.80 (t, J = 7.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 174.6, 158.6, 136.5, 134.9, 133.2, 129.5, 127.5, 126.3, 125.1, 
123.7, 120.5, 118.9, 117.2, 114.5, 108.1, 56.1, 55.3, 40.5, 28.1, 8.4; IR (Neat Film, NaCl) 3163, 
3073, 2973, 2837, 1694, 1640, 1609, 153, 1538, 1514, 1450, 1380, 1304, 1250, 1206, 1184, 
1076, 1034, 919, 890, 819, 768, 750 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C22H24NO2 
[M+H]+: 334.1802 found 334.1816; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): minor = 5.09, major = 5.73. 
 
N
O
Et
OMe
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(R)-2-(3,4-dimethoxyphenyl)-2-ethyl-1-(1H-indol-1-yl)pent-4-en-1-one (2g) 
Purified by column chromatography (20% Et2O in hexanes) to provide an amorphous white solid 
(72.6 mg, 99% yield); 95% ee, [α]D25 –96.6 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.61 
(dt, J = 8.3, 0.9 Hz, 1H), 7.53 (dt, J = 7.7, 1.0 Hz, 1H), 7.40 (ddd, J = 8.2, 7.2, 1.3 Hz, 1H), 7.33–
7.28 (m, 1H), 6.98 (d, J = 3.8 Hz, 1H), 6.96–6.87 (m, 2H), 6.78 (d, J = 1.7 Hz, 1H), 6.34 (dt, J = 
3.8, 0.8 Hz, 1H), 5.56–5.43 (m, 1H), 5.09–4.97 (m, 2H), 3.95 (s, 3H), 3.86 (s, 3H), 3.01 (dd, J = 
14.0, 8.5 Hz, 1H), 2.91 (dd, J = 14.0, 6.2 Hz, 1H), 2.26 (q, J = 7.5 Hz, 2H), 0.91–0.78 (m, 3H); 
13C NMR (100 MHz, CDCl3) δ 174.5, 149.5, 148.1, 136.4, 135.3, 133.1, 129.5, 126.1, 125.0, 
123.7, 120.5, 118.9, 118.5, 117.0, 111.3, 109.6, 108.1, 56.3, 56.0, 55.9, 40.4, 28.0, 8.3. IR (Neat 
Film, NaCl) 3072, 2967, 2835, 1694, 1640, 1587, 1518, 1449, 1412, 1306, 1260, 1206, 1150, 
1077, 1027, 917, 893, 803, 768, 751 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C23H26NO3 
[M+H]+: 364.1907 found 364.1892; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): minor = 4.14, major = 4.92. 
N
O
Et
OMe
OMe
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(R)-2-(4-chlorophenyl)-2-ethyl-1-(1H-indol-1-yl)pent-4-en-1-one (2h) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (68.2 mg, 
99% yield); 94% ee, [α]D25 –103.2 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.57 (d, J = 8.3 
Hz, 1H), 7.48 (d, J = 7.7 Hz, 1H), 7.39–7.32 (m, 3H), 7.30–7.23 (m, 1H), 7.23–7.18 (m, 2H), 
6.81 (dd, J = 3.9, 0.8 Hz, 1H), 6.31 (dd, J = 3.9, 0.7 Hz, 1H), 5.48–5.38 (m, 1H), 5.05–4.92 (m, 
2H), 2.97 (ddt, J = 14.1, 8.4, 0.9 Hz, 1H), 2.84 (ddt, J = 13.9, 6.1, 1.3 Hz, 1H), 2.23 (q, J = 7.4 
Hz, 2H), 0.82 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 173.7, 141.6, 136.5, 133.3, 
132.6, 129.5, 129.4, 127.9, 125.8, 125.3, 123.9, 120.7, 119.4, 117.2, 108.6, 56.5, 40.6, 28.1, 8.4; 
IR (Neat Film, NaCl) 3074, 2974, 2880, 1695, 1639, 1539, 1493, 1450, 1304, 1224, 1206, 1150, 
1097, 1077, 1014, 920, 890, 815, 768, 752 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C21H21ClNO [M+H]+: 338.1306 found 338.1291; SFC Conditions: 15% IPA, 2.5 mL/min, 
Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 4.31, major = 4.78. 
N
O
Et
Cl
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(R)-2-(4-bromophenyl)-2-ethyl-1-(1H-indol-1-yl)pent-4-en-1-one (2i) 
Purified by column chromatography (5% Et2O in hexanes) to provide as a white foam (75.2 mg, 
98% yield); 94% ee, [α]D25 –83.1 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.45 (d, J = 9.6 
Hz, 1H), 7.59 (d, J = 2.0 Hz, 1H), 7.44 (dd, J = 8.9, 2.0 Hz, 1H), 7.37 (dd, J = 8.1, 6.8 Hz, 2H), 
7.33–7.26 (m, 1H), 7.29–7.23 (m, 2H), 6.84 (d, J = 3.8 Hz, 1H), 6.20 (dd, J = 3.9, 0.7 Hz, 1H), 
5.44 (dddd, J = 16.6, 10.0, 8.5, 6.1 Hz, 1H), 5.05–4.89 (m, 2H), 3.02–2.91 (m, 1H), 2.87 (dd, J = 
14.1, 6.2 Hz, 1H), 2.33–2.14 (m, 2H), 0.80 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
174.3, 142.7, 135.2, 132.8, 131.3, 129.3, 127.9, 127.5, 127.2, 126.4, 123.2, 119.2, 118.5, 117.0, 
107.3, 56.8, 40.3, 28.0, 8.3; IR (Neat Film, NaCl) 3162, 3065, 2974, 2879, 1698, 1639, 1598, 
1574, 1534, 1496, 1443, 1364, 1304, 1266, 1218, 1199, 1080, 1032, 1000, 947, 920, 887, 822, 
811, 762, 734, 718, 702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H21BrNO [M+H]+: 
382.0801 found 382.0785; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 
210 nm, tR (min): minor = 6.60, major = 7.38. 
N
O
Et
Br
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(R)-2-ethyl-2-(4-fluorophenyl)-1-(1H-indol-1-yl)pent-4-en-1-one (2j) 
Purified by column chromatography (5% Et2O in hexanes) to provide an amorphous white solid 
(62.1mg, 97% yield); 96% ee, [α]D25 –97.3 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.57 
(d, J = 8.4 Hz, 1H), 7.46 (d, J = 7.7 Hz, 1H), 7.35 (t, J = 7.8 Hz, 1H), 7.27–7.19 (m, 3H), 7.05 (t, 
J = 8.5 Hz, 2H), 6.81 (d, J = 3.9 Hz, 1H), 6.29 (d, J = 3.8 Hz, 1H), 5.42 (dtd, J = 16.8, 9.0, 6.3 
Hz, 1H), 5.02–4.89 (m, 2H), 2.95 (dd, J = 14.0, 8.4 Hz, 1H), 2.83 (dd, J = 14.0, 6.2 Hz, 1H), 
2.21 (q, J = 7.4 Hz, 2H), 0.79 (t, J = 7.4 Hz, 3H); 19F NMR (282 MHz, CDCl3) δ –114.82 (tt, J = 
9.1, 4.7 Hz); 13C NMR (100 MHz, CDCl3) δ 174.0, 162.0 (d, JC–F = 246.9 Hz), 138.9 (d, JC–F = 
3.4 Hz), 136.5, 132.8, 129.5, 128.10 (d, JC–F = 7.9 Hz), 125.9, 125.2, 123.9, 120.7, 119.3, 117.3, 
116.1 (d, JC–F = 21.4 Hz), 108.4, 56.3, 40.7, 28.2, 8.4; IR (Neat Film, NaCl) 3073, 2973, 1694, 
1602, 1539, 1510, 1450, 1305, 1226, 1206, 1164, 1102, 1077, 1016, 920, 890, 822, 810, 768, 751 
cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H21FNO [M+H]+: 322.1602 found 322.1607; 
SFC Conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 
4.57, major = 5.07. 
N
O
Et
F
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(R)-2-ethyl-1-(1H-indol-1-yl)-2-(4-(trifluoromethyl)phenyl)pent-4-en-1-one (2k) 
Purified by column chromatography (5% Et2O in hexanes) to provide an amorphous white solid 
(73.0 mg, 98% yield); 70% ee, [α]D25 –75.6 (c 1.0, CHCl3);	1H NMR (500 MHz, CDCl3) δ 8.58 
(dt, J = 8.3, 0.8 Hz, 1H), 7.63 (d, J = 8.2 Hz, 2H), 7.48 (dd, J = 7.7, 1.1 Hz, 1H), 7.42–7.35 (m, 
3H), 7.29–7.24 (m, 1H), 6.73 (d, J = 3.9 Hz, 1H), 6.31 (d, J = 3.9 Hz, 1H), 5.42 (dddd, J = 16.6, 
10.2, 8.4, 6.2 Hz, 1H), 5.06–4.92 (m, 2H), 3.01 (dd, J = 14.0, 8.4 Hz, 1H), 2.88 (dd, J = 14.1, 6.3 
Hz, 1H), 2.28 (qd, J = 7.3, 2.2 Hz, 2H), 0.83 (t, J = 7.4 Hz, 3H); 19F NMR (376 MHz, CDCl3) δ -
62.67; 13C NMR (100 MHz, CDCl3) δ 173.3, 147.2 (overlapping), 136.5, 132.3, 129.6 (q, J = 
32.7 Hz), 129.5, 127.0, 126.1 (q, J = 3.8 Hz), 125.5, 125.4, 124.1, 124.1 (q, J = 272.2 Hz), 120.7, 
119.7, 117.3, 108.8, 56.9, 40.6, 28.1, 8.4. IR (Neat Film, NaCl) 3076, 2977, 2882, 1697, 1618, 
1549, 1450, 1412, 1328, 1307, 1225, 1207, 1169, 1126, 1070, 1017, 922, 890, 843, 819, 768, 751 
cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C22H21F3NO [M+H]+: 372.1570 found 372.1555; 
SFC Conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 
4.48, major = 4.97. 
N
O
Et
CF3
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(R)-2-ethyl-1-(5-methyl-1H-indol-1-yl)-2-phenylpent-4-en-1-one (2l) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (63.4mg, 
99% yield); 98% ee, [α]D25 –111.7 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.45 (d, J = 8.5 
Hz, 1H), 7.37–7.32 (m, 2H), 7.31–7.23 (m, 4H), 7.18 (dd, J = 8.5, 1.7 Hz, 1H), 6.80 (d, J = 3.9 
Hz, 1H), 6.19 (d, J = 3.8 Hz, 1H), 5.44 (dddd, J = 16.7, 10.3, 8.5, 6.2 Hz, 1H), 5.02–4.93 (m, 
2H), 2.98 (dd, J = 14.0, 8.5 Hz, 1H), 2.90–2.83 (m, 1H), 2.43 (s, 3H), 2.24 (qd, J = 7.4, 1.5 Hz, 
2H), 0.80 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 174.1, 143.1, 134.7, 133.3, 133.1, 
129.8, 129.1, 127.3, 126.5, 126.4, 126.1, 120.5, 118.9, 116.9, 108.0, 56.7, 40.5, 28.0, 21.4, 8.4; 
IR (Neat Film, NaCl) 3024, 2974, 2879, 1694, 1640, 1542, 1494, 1466, 1365, 1305, 1245, 1207, 
1142, 1079, 1000, 919, 889, 830, 810, 766, 734, 716, 702 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C22H24NO [M+H]+: 318.1852 found 318.1846; SFC Conditions: 15% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 5.21, major = 5.92. 
N
O
EtMe
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(R)-1-(5-bromo-1H-indol-1-yl)-2-ethyl-2-phenylpent-4-en-1-one (2m) 
Purified by column chromatography (5% Et2O in hexanes) to provide an amorphous white foam 
(74.0 mg, 97% yield); 92% ee, [α]D25 –112.5 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.57 
(dq, J = 8.4, 0.9 Hz, 1H), 7.51–7.45 (m, 3H), 7.36 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.28–7.24 (m, 
1H), 7.17–7.11 (m, 2H), 6.81 (d, J = 3.9 Hz, 1H), 6.31 (dd, J = 3.9, 0.8 Hz, 1H), 5.43 (dddd, J = 
16.6, 10.1, 8.4, 6.2 Hz, 1H), 5.03–4.92 (m, 2H), 2.96 (ddt, J = 14.0, 8.4, 1.0 Hz, 1H), 2.86–2.80 
(m, 1H), 2.22 (q, J = 7.4 Hz, 2H), 0.81 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 173.6, 
142.1, 136.5, 132.6, 132.3, 129.5, 128.2, 125.8, 125.3, 123.9, 121.4, 120.7, 119.4, 117.2, 108.6, 
56.5, 40.5, 28.0, 8.4; IR (Neat Film, NaCl) 3073, 2974, 1694, 1586, 1537, 1492, 1450, 1305, 
1224, 1206, 1149, 1076, 1010, 920, 890, 814, 768, 752 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C21H21BrNO [M+H]+: 382.0801 found 382.0811; SFC Conditions: 15% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 5.28, major = 5.91. 
N
O
EtBr
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(R)-2-ethyl-1-(3-methyl-1H-pyrrol-1-yl)-2-(o-tolyl)pent-4-en-1-one (2n) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (56.1 mg, 
99% yield); 89% ee, [α]D25 –87.4 (c 1.0, CHCl3); Note: Rotameric species were observed for this 
compound, thus the 1H NMR spectrum was recorded at elevated temperature (50 ºC): 1H NMR 
(400 MHz, CDCl3, 50 ºC) δ 7.37 (dt, J = 8.0, 1.5 Hz, 1H), 7.30–7.21 (m, 1H), 7.18 (tt, J = 7.2, 
1.4 Hz, 1H), 7.08 (d, J = 7.5 Hz, 1H), 6.77 (d, J = 10.9 Hz, 2H), 5.84 (dt, J = 3.2, 1.5 Hz, 1H), 
5.39 (s, 1H), 5.05–4.90 (m, 2H), 2.90 (d, J = 7.3 Hz, 2H), 2.26 (dd, J = 13.1, 6.6 Hz, 1H), 2.14 
(d, J = 11.3 Hz, 2H), 2.13 (s, 2H), 1.91 (d, J = 1.3 Hz, 3H), 0.77 (s, 3H); Note: Rotameric species 
were observed for this compound, thus the 13C NMR spectrum contains broad peaks: 13C NMR 
(100 MHz, CDCl3) δ 173.5, 140.8, 136.8, 133.3, 132.7, 127.3, 126.4, 126.1, 122.5, 120.4, 118.8, 
117.4, 114.4, 54.6, 37.8, 28.0, 20.3, 12.0, 8.4; IR (Neat Film, NaCl) 3143, 3073, 2976, 2880, 
1699, 1639, 1490, 1459, 1490, 1459, 1389, 1337, 1309, 1199, 1134, 1080, 1068,990, 918, 893, 
827, 773, 740 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H24NO [M+H]+: 282.1852 
found 282.1843; SFC Conditions: 3% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 210 nm, tR 
(min): minor = 4.99, major = 5.37. 
N
O
Me
Et
Me
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(R)-2-(2-bromophenyl)-2-ethyl-1-(3-methyl-1H-pyrrol-1-yl)pent-4-en-1-one (2o) 
Purified by column chromatography (5% Et2O in hexanes) to provide an amorphous white solid 
(60.1 mg, 87% yield); 80% ee, [α]D25 –80.9 (c 1.0, CHCl3); Note: Rotameric species were 
observed for this compound, thus the 1H NMR spectrum was recorded at elevated temperature 
(50 ºC): 1H NMR (400 MHz, CDCl3) δ 7.55 (dt, J = 8.0, 1.4 Hz, 1H), 7.45 (dd, J = 8.0, 1.8 Hz, 
1H), 7.43–7.36 (m, 1H), 7.16 (td, J = 7.5, 1.6 Hz, 1H), 6.74 (d, J = 9.1 Hz, 2H), 5.86 (dd, J = 3.4, 
1.7 Hz, 1H), 5.46–5.24 (m, 1H), 5.04–4.92 (m, 2H), 3.14 (dd, J = 14.4, 6.3 Hz, 1H), 3.01–2.85 
(m, 1H), 2.46–2.33 (m, 1H), 2.19–2.05 (m, 1H), 1.92 (s, 3H), 0.80 (s, 3H); Note: Rotameric 
species were observed for this compound, thus the 13C NMR spectrum contains broad peaks: 13C 
NMR (100 MHz, CDCl3) δ 171.5, 141.8, 135.3, 132.9, 129.0, 128.5, 127.8, 124.2, 122.5, 120.2, 
119.1, 117.4, 114.4, 55.8, 36.5, 28.0, 12.1, 8.8; IR (Neat Film, NaCl) 2977, 1704, 1485, 1470, 
1390, 1309, 1201, 1134, 1068, 1025, 919, 828, 769, 741 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C18H21BrNO [M+H]+: 346.0801 found 346.0790; SFC Conditions: 3% IPA, 2.5 
mL/min, Chiralpak OD-H column, λ = 210 nm, tR (min): minor = 9.10, major = 9.72. 
N
O
Me
Et
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(S)-2-ethyl-1-(1H-indol-1-yl)-2-(1H-pyrrol-1-yl)pent-4-en-1-one (2p) 
Purified by column chromatography (2% Et2O in hexanes) to provide colorless oil (56.8 mg, 
97% yield); 99% ee, [a]D25 104.2 (c 0.25, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.54 (dd, J = 
8.3, 0.9 Hz, 1H), 7.49 (ddd, J = 7.7, 1.3, 0.7 Hz, 1H), 7.36 (ddd, J = 8.5, 7.3, 1.3 Hz, 1H), 7.29–
7.25 (m, 1H), 6.80 (t, J = 2.2 Hz, 2H), 6.39–6.18 (m, 4H), 5.38 (dddd, J = 16.8, 10.2, 8.0, 6.5 Hz, 
1H), 5.17–4.91 (m, 2H), 3.10–2.95 (m, 2H), 2.45–2.22 (m, 2H), 0.86 (t, J = 7.5 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 170.5, 136.8, 131.2, 129.7, 125.3, 124.6, 124.1, 120.7, 120.23, 118.6, 
117.1, 109.9, 69.6, 40.4, 28.4, 8.1; IR (Neat Film, NaCl) 3156, 2978, 1697, 1538, 1450, 1381, 
1356, 1309, 1227, 1204, 1152, 1079, 926, 880, 821, 751, 723 cm–1; HRMS (MM:ESI-APCI+) 
m/z calc’d for C19H21N2O [M+H]+: 293.1648 found 293.1641; SFC Conditions: 6% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 7.81, major = 8.64. 
 
N
O
N
Et
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Selective Enolization of N-Acyl Substrates 
 
To a flame-dried flask was added LHMDS (335 mg, 2 mmol) followed by toluene (3.0 mL) and 
N,N-dimethylethylamine (0.213 mL, 2 mmol), and the resulting mixture stirred at 25 °C for 5 
min.  A solution of N-acyl indole (1 mmol) in toluene (2.0 mL) was then added, and the reaction 
stirred at 25 °C for an additional 2 hours.  The flask was then submerged in a room temperature 
water bath, and allyl chloroformate (0.217 mL, 2 mmol) was added neat, and the reaction 
continued until no starting material remained by TLC (typically less than 30 min).  The crude 
reaction mixture was diluted with Et2O and quenched with water.  The layers were separated, 
and the aqueous layer was extracted with Et2O twice.  The combined organic layers were dried 
over Na2SO4 and concentrated.  The crude product was purified by silica gel flash 
chromatography to afford the desired enol carbonate.  The E/Z ratio of enol carbonates was 
determined by 1H NMR and is >95:5 unless stated otherwise. 
 
 
LHMDS (2 equiv)
Me2NEt (2 equiv)
toluene, 25 °C
then allyl chloroformate
N
O
R
Ar
N
O
O
O
R
Ar
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(E)-1-(1H-indol-1-yl)-2-phenylbut-1-en-1-yl allyl carbonate (1a) 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
colorless oil (2.08 g, 75% yield); 1H NMR (500 MHz, CDCl3) δ 7.55–7.43 (m, 2H), 7.24–7.18 
(m, 1H), 7.15–7.06 (m, 4H), 7.02–6.94 (m, 2H), 6.89 (d, J = 3.3 Hz, 1H), 6.35 (dd, J = 0.9, 3.4 
Hz, 1H), 5.88 (ddt, J = 5.8, 10.4, 17.1 Hz, 1H), 5.37–5.23 (m, 2H), 4.61 (dt, J = 1.4, 5.8 Hz, 2H), 
2.68 (q, J = 7.5 Hz, 2H), 1.09 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 152.7, 136.2, 
135.0, 130.8, 130.2, 129.0, 128.4, 128.2, 127.5, 127.5, 122.6, 120.7, 119.4, 111.2, 103.9, 69.3, 
24.9, 12.6; IR (Neat Film, NaCl) 3056, 2974, 1766, 1682, 1519, 1456, 1333, 1259, 1238, 1209, 
1143, 1119, 1094, 1042, 968, 946, 913, 765, 743, 699 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d 
for C22H22NO3 [M+H]+: 348.1594, found 348.1588. 
 
 
(E)-1-(1H-indol-1-yl)-2-phenylhept-1-en-1-yl allyl carbonate (1b) 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
colorless oil (337.6 mg, 87% yield); 1H NMR (500 MHz, CDCl3) δ 7.51–7.45 (m, 2H), 7.23–
7.16 (m, 1H), 7.14–7.05 (m, 4H), 6.98–6.91 (m, 2H), 6.89–6.84 (m, 1H), 6.36–6.30 (m, 1H), 
5.94–5.81 (m, 1H), 5.36–5.22 (m, 2H), 4.60 (dq, J = 5.8, 1.4 Hz, 2H), 2.70–2.60 (m, 2H), 1.49–
1.26 (m, 6H), 0.89 (td, J = 7.1, 1.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 152.7, 136.4, 136.3, 
135.4, 130.9, 129.1, 129.0, 128.4, 128.2, 127.5, 127.5, 122.6, 120.7, 120.7, 119.4, 111.2, 103.9, 
69.3, 31.5, 31.4, 27.3, 22.4, 14.1; IR (Neat Film, NaCl) 3055, 2956, 2929, 2860, 2363, 2340, 
1765, 1684, 1457, 1332, 1242, 1211, 1142, 1118, 948, 764, 742, 699 cm-1; HRMS (MM:ESI-
APCI+) m/z calc’d for C25H28NO3 [M+H]+: 390.2064, found 390.2078. 
N
O O
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(E)-1-(1H-indol-1-yl)-4-methyl-2-phenylpent-1-en-1-yl allyl carbonate (1c) 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
white solid (327.6 mg, 87% yield); 1H NMR (500 MHz, CDCl3) δ 7.50 (ddd, J = 7.4, 5.8, 1.0 Hz, 
2H), 7.21 (ddd, J = 8.3, 7.1, 1.1 Hz, 1H), 7.15–7.08 (m, 4H), 6.99–6.91 (m, 2H), 6.84 (d, J = 3.3 
Hz, 1H), 6.33 (d, J = 3.3 Hz, 1H), 5.88 (ddt, J = 17.3, 10.5, 5.8 Hz, 1H), 5.32 (dq, J = 17.1, 1.5 
Hz, 1H), 5.26 (dq, J = 10.3, 1.3 Hz, 1H), 4.60 (dt, J = 5.8, 1.4 Hz, 2H), 2.56 (d, J = 7.3 Hz, 2H), 
1.62 (hept, J = 6.8 Hz, 1H), 1.00 (d, J = 6.6 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 152.6, 
136.5, 136.3, 136.1, 130.9, 129.2, 128.4, 128.2, 128.0, 127.5, 127.4, 122.6, 120.7, 120.7, 119.4, 
111.2, 103.8, 69.3, 40.2, 26.5, 22.4; IR (Neat Film, NaCl) 3057, 3031, 2957, 2869, 1766, 1682, 
1519, 1456, 1331, 1246, 1331, 1246, 1209, 1144, 1118, 1046, 960, 767, 743, 699 cm-1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C24H26NO3 [M+H]+: 376.1907, found 376.1902. 
 
 
 
 
 
(E)-1-(1H-indol-1-yl)-2,3-diphenylprop-1-en-1-yl allyl carbonate (1d) 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
yellow oil (377.6 mg, 92% yield);	1H NMR (500 MHz, CHCl3) δ 7.58–7.49 (m, 2H), 7.34–7.25 
(m, 4H), 7.26–7.18 (m, 2H), 7.14 (tt, J = 7.1, 0.9 Hz, 1H), 7.07–6.99 (m, 3H), 6.95 (m, 1H), 
6.94–6.87 (m, 2H), 6.39 (dt, J = 3.4, 0.8 Hz, 1H), 5.91–5.79 (m, 1H), 5.35–5.22 (m, 2H), 4.58 
(dt, J = 5.9, 1.3 Hz, 2H), 4.03 (s, 2H); 13C NMR (100 MHz, CHCl3) δ 152.4, 138.0, 136.5, 136.1, 
136.1, 130.7, 128.9, 128.8, 128.5, 128.4, 128.1, 127.7, 127.5, 126.6, 126.4, 122.7, 120.9, 120.8, 
119.4, 111.3, 104.2, 69.4, 37.7; IR (Neat Film, NaCl) 3059, 3028, 1766, 1678, 1602, 1519, 1495, 
1456, 1384, 1364, 1333, 1243, 1214, 1142, 1117, 967, 945 cm-1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C27H24NO3 [M+H]+: 410.1751, found 410.1749. 
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(E)-1-(1H-indol-1-yl)-2-(p-tolyl)but-1-en-1-yl allyl carbonate (1e) 
Purified by column chromatography (6% Et2O in hexanes) to provide the desired product as a 
yellow oil (268.7 mg, 74% yield); 1H NMR (500 MHz, CDCl3) δ 7.54–7.42 (m, 2H), 7.19 (ddd, J 
= 8.3, 7.1, 1.2 Hz, 1H), 7.10 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 6.92–6.80 (m, 5H), 6.35 (dd, J = 3.3, 
0.9 Hz, 1H), 5.87 (ddt, J = 17.2, 10.5, 5.8 Hz, 1H), 5.41–5.18 (m, 2H), 4.59 (dt, J = 5.8, 1.4 Hz, 
2H), 2.64 (q, J = 7.5 Hz, 2H), 2.19 (s, 3H), 1.07 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 152.8, 137.2, 136.3, 134.8, 133.2, 130.9, 130.3, 129.2, 129.0, 128.5, 127.5, 122.6, 
120.8, 120.7, 119.6, 111.4, 103.8, 69.4, 25.0, 21.2, 12.7; IR (Neat Film, NaCl) 1764, 1457, 1333, 
1258, 1238, 1209, 1143, 1120, 945, 818, 743 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C23H24NO3 [M+H]+: 362.1751, found 362.1741. 
 
 
(E)-1-(1H-indol-1-yl)-2-(4-methoxyphenyl)but-1-en-1-yl allyl carbonate (1f) 
Purified by column chromatography (10% Et2O in hexanes) to provide the desired product as a 
yellow oil (245.6 mg, 65% yield); 1H NMR (500 MHz, CDCl3) δ 7.51 (ddd, J = 7.8, 1.2, 0.8 Hz, 
1H), 7.45 (dq, J = 8.2, 0.9 Hz, 1H), 7.19 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.10 (ddd, J = 8.0, 7.1, 
1.0 Hz, 1H), 6.92–6.82 (m, 3H), 6.67– 6.57 (m, 2H), 6.36 (dd, J = 3.3, 0.9 Hz, 1H), 5.87 (ddt, J = 
17.2, 10.4, 5.8 Hz, 1H), 5.37–5.19 (m, 2H), 4.59 (d, J = 5.8 Hz, 2H), 3.68 (s, 3H), 2.63 (q, J = 
7.5 Hz, 2H), 1.07 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 158.9, 152.9, 136.3, 134.6, 
131.0, 129.9, 129.2, 128.8, 128.5, 128.3, 122.7, 120.8, 120.8, 119.6, 113.7, 111.4, 103.9, 69.5, 
55.2, 25.0, 12.8; IR (Neat Film, NaCl) 1764, 1609, 1513, 1456, 1293, 1247, 1209, 1142, 1121, 
1038, 831, 744 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C23H24NO4 [M+H]+: 378.1700, 
found 378.1690. 
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(E)-allyl (2-(3,4-dimethoxyphenyl)-1-(1H-indol-1-yl)but-1-en-1-yl) carbonate (1g) 
Purified by column chromatography (20% Et2O in hexanes) to provide the desired product as a 
colorless oil (262.1 mg, 64% yield); 1H NMR (500 MHz, CDCl3) δ 7.54–7.48 (m, 2H), 7.21 
(ddd, J = 1.3, 7.1, 8.3 Hz, 1H), 7.11 (td, J = 1.1, 7.5 Hz, 1H), 6.92 (t, J = 2.2 Hz, 1H), 6.71 (dt, J 
= 1.9, 8.3 Hz, 1H), 6.66 (d, J = 8.4 Hz, 1H), 6.38 (dt, J = 1.2, 3.5 Hz, 1H), 6.17 (t, J = 1.8 Hz, 
1H), 5.89 (ddt, J = 5.8, 10.3, 17.1 Hz, 1H), 5.41–5.19 (m, 2H), 4.62 (dt, J = 1.4, 5.8 Hz, 2H), 
3.77 (s, 3H), 3.23 (s, 3H), 2.68 (qd, J = 2.4, 7.6 Hz, 2H), 1.12 (td, J = 2.2, 7.5 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 152.9, 148.4, 148.3, 136.6, 134.5, 130.9, 130.6, 129.2, 128.4, 128.4, 122.7, 
120.8, 120.8, 119.7, 119.6, 111.1, 110.7, 110.6, 104.0, 69.4, 55.7, 55.2, 24.7, 12.9; IR (Neat 
Film, NaCl) 1763, 1518, 1456, 1262, 1242, 1208, 1139, 1116, 1026, 946, 766, 744 cm-1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C24H26NO5 [M+H]+: 408.1805, found 408.1817. 
 
(E)-allyl (2-(4-chlorophenyl)-1-(1H-indol-1-yl)but-1-en-1-yl) carbonate (1h) 
Purified by column chromatography (8% Et2O in hexanes) to provide the desired product as a 
light yellow oil (356.3 mg, 93% yield); 1H NMR (500 MHz, CDCl3) δ 7.53–7.48 (m, 1H), 7.43 
(dq, J = 0.9, 8.2 Hz, 1H), 7.19 (ddd, J = 1.2, 7.1, 8.2 Hz, 1H), 7.11 (ddd, J = 1.0, 7.1, 8.0 Hz, 
1H), 7.09–7.03 (m, 2H), 6.92–6.82 (m, 3H), 6.37 (dd, J = 0.9, 3.4 Hz, 1H), 5.86 (ddt, J = 5.8, 
10.5, 17.2 Hz, 1H), 5.36–5.23 (m, 2H), 4.59 (dt, J = 1.3, 5.8 Hz, 2H), 2.64 (q, J = 7.5 Hz, 2H), 
1.06 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 152.6, 136.2, 135.4, 134.8, 133.4, 130.8, 
129.2, 129.0, 128.9, 128.6, 128.5, 122.9, 121.0, 120.9, 119.8, 111.2, 104.4, 69.6, 24.9, 12.7; IR 
(Neat Film, NaCl) 1765, 1679, 1456, 1333, 1256, 1238, 1209, 1144, 1120, 1096, 945, 827, 743 
cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C22H21ClNO3 [M+H]+: 382.1204, found 382.1201. 
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(E)-allyl (2-(4-bromophenyl)-1-(1H-indol-1-yl)but-1-en-1-yl) carbonate (1i) 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as an 
amorphous white solid (341.0 mg, 80% yield);	1H NMR (400 MHz, CDCl3) δ 7.53–7.49 (m, 1H), 
7.43 (dd, J = 8.2, 0.9 Hz, 1H), 7.24–7.17 (m, 3H), 7.14–7.09 (m, 1H), 6.86 (d, J = 3.4 Hz, 1H), 
6.86–6.78 (m, 2H), 6.37 (d, J = 3.1 Hz, 1H), 5.86 (ddt, J = 17.3, 10.4, 5.8 Hz, 1H), 5.36–5.23 (m, 
2H), 4.59 (dt, J = 5.8, 1.4 Hz, 2H), 2.64 (q, J = 7.5 Hz, 2H), 1.06 (t, J = 7.5 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 152.6, 136.1, 135.3, 135.2, 131.5, 130.8, 129.3, 129.2, 128.8, 128.5, 122.8, 
121.6, 121.0, 120.9, 119.7, 111.2, 104.4, 69.5, 24.8, 12.7; IR (Neat Film, NaCl) 3053, 3032, 
2974, 2937, 2876, 2248, 1899, 1766, 1681, 1588, 1519, 1488, 1455, 1385, 1364, 1333, 1238, 
1209, 1144, 1120, 945, 824, 766, 743 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C22H21BrNO3 [M+H]+: 426.0699,  found 426.0696. 
 
(E)-allyl (2-(4-fluorophenyl)-1-(1H-indol-1-yl)but-1-en-1-yl) carbonate (1j) 
 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
colorless oil (312.6 mg, 86% yield); 1H NMR (500 MHz, CDCl3) δ 7.47 (dd, J = 37.4, 8.0 Hz, 
2H), 7.15 (dt, J = 41.2, 7.4 Hz, 2H), 6.97–6.86 (m, 3H), 6.82–6.74 (m, 2H), 6.38 (d, J = 3.3 Hz, 
1H), 5.88 (ddt, J = 16.7, 11.2, 5.8 Hz, 1H), 5.36–5.24 (m, 2H), 4.65–4.55 (m, 2H), 2.66 (q, J = 
7.5 Hz, 2H), 1.08 (t, J = 7.5 Hz, 3H); 19F NMR (282 MHz, CDCl3) δ –114.05 – –114.17 (m); 13C 
NMR (100 MHz, CDCl3) δ 162.0 (d, J = 247.1 Hz), 152.7, 136.2, 135.2, 132.1 (d, JC–F = 4.0 Hz), 
130.8, 129.4, 129.3 (d, JC–F = 8.2 Hz), 128.8, 128.4, 122.7, 120.9, 120.8, 119.6, 115.3 (d, JC–F = 
21.6 Hz), 111.2, 104.2, 69.5, 25.0, 12.6;  IR (Neat Film, NaCl) 2974, 1766, 1681, 1604, 1510, 
N
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1456, 1333, 1238, 1208, 1144, 1119, 945, 835, 765, 743 cm-1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C22H21FNO3 [M+H]+: 366.1500, found 366.1502. 
 
 
(E)-1-(1H-indol-1-yl)-2-(4-(trifluoromethyl)phenyl)but-1-en-1-yl allyl carbonate (1k) 
 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
white solid (375.1 mg, 90% yield); 1H NMR (500 MHz, CDCl3) δ 7.54 (dt, J = 1.0, 7.8 Hz, 1H), 
7.49 (dq, J = 1.0, 8.2 Hz, 1H), 7.41–7.34 (m, 2H), 7.28–7.21 (m, 1H), 7.19–7.08 (m, 3H), 6.87 
(d, J = 3.3 Hz, 1H), 6.40 (dd, J = 0.9, 3.4 Hz, 1H), 5.89 (ddt, J = 5.9, 10.5, 17.2 Hz, 1H), 5.38–
5.25 (m, 2H), 4.63 (dt, J = 1.4, 5.8 Hz, 2H), 2.72 (q, J = 7.5 Hz, 2H), 1.11 (t, J = 7.5 Hz, 3H); 19F 
NMR (282 MHz, CDCl3) δ –62.73; 13C NMR (100 MHz, CDCl3) δ 152.6, 140.2, 136.2, 136.0, 
130.8, 129.5 (q, J = 32.5 Hz), 129.0, 128.8, 128.5, 128.1, 125.4 (q, J = 272 Hz), 125.4–125.2 
(m), 123.0, 121.1, 121.0, 119.8, 111.2, 104.6, 69.7, 24.9, 12.6; IR (Neat Film, NaCl) 1766, 1681, 
1617, 1456, 1325, 1260, 1239, 1211, 1167, 1123, 1067, 946, 834, 744 cm-1; HRMS (MM:ESI-
APCI+) m/z calc’d for C23H21F3NO3 [M+H]+: 416.1468, found 416.1456. 
 
 
(E)-allyl (1-(5-methyl-1H-indol-1-yl)-2-phenylbut-1-en-1-yl) carbonate (1l) 
Purified by column chromatography (hexanes → 5% Et2O in hexanes) to provide the desired 
product as a yellow oil (336.3 mg, 93% yield); 1H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 8.3 
Hz, 1H), 7.30–7.28 (m, 1H), 7.12–7.08 (m, 3H), 7.02 (d, J = 8.3 Hz, 1H), 6.97 (dd, J = 6.4, 2.9 
Hz, 2H), 6.83 (d, J = 3.3 Hz, 1H), 6.30–6.18 (m, 1H), 5.94–5.82 (m, 1H), 5.37–5.24 (m, 2H), 
4.63–4.55 (m, 2H), 2.67 (q, J = 7.5 Hz, 2H), 2.42 (s, 3H), 1.09 (t, J = 7.5 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 152.7, 136.3, 135.3, 134.6, 130.9, 130.0, 129.8, 129.1, 128.7, 128.3, 127.7, 
127.5, 124.2, 120.6 119.5, 111.0, 103.6, 69.4, 25.0, 21.5, 12.7; IR (Neat Film, NaCl) 3023, 2974, 
N
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2875, 1766, 1682, 1470, 1377, 1330, 1260, 1230, 1209, 1163, 1125, 1095, 1042, 967, 946, 843, 
796, 763, 718, 699 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C23H24NO3 [M+H]+: 362.1751, 
found 362.1751. 
 
 
(E)-allyl (1-(5-bromo-1H-indol-1-yl)-2-phenylbut-1-en-1-yl) carbonate (1m) 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as an 
amorphous white solid (352.3 mg, 83% yield); 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 1.9 
Hz, 1H), 7.29 (d, J = 8.6 Hz, 1H), 7.24 (dd, J = 8.6, 1.9 Hz, 1H), 7.12–7.08 (m, 3H), 6.94 (dd, J 
= 6.7, 3.0 Hz, 2H), 6.91 (d, J = 3.4 Hz, 1H), 6.29 (d, J = 3.3 Hz, 1H), 5.92–5.82 (m, 1H), 5.36–
5.24 (m, 2H), 4.61 (dt, J = 5.8, 1.4 Hz, 2H), 2.66 (q, J = 7.5 Hz, 2H), 1.07 (t, J = 7.5 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 152.7, 136.0, 134.9, 134.5, 131.0, 130.8, 130.2, 130.1, 128.4, 
127.8, 127.5, 125.5, 123.3, 119.8, 114.1, 112.8, 103.5, 69.6, 25.0, 12.6; IR (Neat Film, NaCl) 
2973, 2934, 2873, 1764, 1679, 1452, 1375, 1236, 1208, 1128, 945, 758, 698 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C22H21BrNO3 [M+H]+: 426.0699, found 426.0696. 
 
(E)-allyl (1-(3-methyl-1H-pyrrol-1-yl)-2-(o-tolyl)but-1-en-1-yl) carbonate (1n) 
Purified by column chromatography (2.5% Et2O in hexanes) to provide the desired product as a 
colorless oil (533.2 mg, 75% yield) Note: compound darkens in color overtime under argon at –
20 °C; 1H NMR (500 MHz, CDCl3) δ 7.17–7.07 (m, 4H), 6.34 (dd, J = 2.9, 2.2 Hz, 1H), 6.29 
(ddd, J = 2.2, 1.7, 1.0 Hz, 1H), 5.95 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.76 (ddd, J = 2.9, 1.7, 0.5 
Hz, 1H), 5.44–5.28 (m, 2H), 4.70 (dq, J = 5.8, 1.4 Hz, 2H), 2.44 (dq, J = 14.9, 7.3 Hz, 2H), 2.11 
(d, J = 0.5 Hz, 3H), 1.91 (d, J = 1.0 Hz, 3H), 0.96 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 152.9, 136.5, 136.3, 136.3, 131.0, 130.2, 129.2, 127.5, 125.7, 122.8, 121.2, 119.6, 
119.6, 118.2, 110.9, 69.5, 25.7, 19.4, 11.9, 11.8; IR (Neat Film, NaCl) 3061, 3019, 2972, 2936, 
2874, 1769, 1688, 1487, 1456, 1350, 1258, 1234, 1185, 1139, 1118, 1070, 1047, 1022, 995, 958, 
N
O O
O
Et
Br
N
O
Me
Et
Me
O
O
Supporting Information for Alexy,‡ Fulton,‡ Zhang, and Stoltz 	
 
S27 
946, 915, 837, 761, 729, 694 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C20H24NO3 [M+H]+: 
326.1751, found 326.1733. 
 
 
(E)-allyl (2-(2-bromophenyl)-1-(3-methyl-1H-pyrrol-1-yl)but-1-en-1-yl) carbonate (1o) 
Purified by column chromatography (3% Et2O in hexanes) to provide the desired product as a 
colorless oil (410 mg, 70% yield) Note: compound darkens in color overtime under argon at –20 
°C; 1H NMR (500 MHz, CDCl3) δ 7.53 (dd, J = 8.0, 1.2 Hz, 1H), 7.18 (td, J = 7.5, 1.3 Hz, 1H), 
7.13–7.03 (m, 2H), 6.50 (dd, J = 2.8, 2.2 Hz, 1H), 6.40 (m, 1H), 5.95 (ddt, J = 17.2, 10.5, 5.8 Hz, 
1H), 5.77 (dd, J = 3.0, 1.7 Hz, 1H), 5.43–5.27 (m, 2H), 4.70 (dt, J = 5.8, 1.3 Hz, 2H), 2.51 (ddq, 
J = 36.7, 14.5, 7.3 Hz, 2H), 1.92 (d, J = 1.0 Hz, 3H), 0.98 (t, J = 7.5 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 152.5, 137.7, 137.4, 132.9, 131.0, 130.9, 129.1, 127.3, 125.0, 123.7, 121.4, 
119.8, 119.6, 118.6, 111.0, 69.6, 24.5, 11.9, 11.8; IR (Neat Film, NaCl) 2972, 2936, 1770, 1692, 
1488, 1470, 1392, 1364, 1350, 1292, 1251, 1231, 1187, 1133, 1070, 1024, 959, 947, 758 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C19H21BrNO3 [M+H]+: 390.0699, found 390.0688. 
 
 
(E)-1-(1H-indol-1-yl)-2-(1H-pyrrol-1-yl)but-1-en-1-yl allyl carbonate (1p) 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
viscous colorless oil (2.33 g, 88% yield); 1H NMR (500 MHz, CDCl3) δ 7.55 (dt, J = 7.7, 1.1 Hz, 
1H), 7.42 (dq, J = 8.2, 0.9 Hz, 1H), 7.21 (ddd, J = 8.3, 7.1, 1.3 Hz, 1H), 7.14 (ddd, J = 8.1, 7.1, 
1.1 Hz, 1H), 6.89 (d, J = 3.4 Hz, 1H), 6.48 (dd, J = 3.4, 0.9 Hz, 1H), 6.38–6.32 (m, 2H), 6.02–
5.97 (m, 2H), 5.87 (ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 5.38–5.24 (m, 2H), 4.61 (dt, J = 5.9, 1.3 Hz, 
2H), 2.72 (q, J = 7.5 Hz, 2H), 1.10 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 152.6, 
136.1, 132.6, 130.7, 130.1, 128.7, 127.8, 123.1, 121.2, 121.0, 120.2, 120.0, 110.8, 109.8, 69.9, 
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24.2, 11.7; IR (Neat Film, NaCl) 2979, 2879, 1769, 1703, 1520, 1482, 1456, 1383, 1482, 1456, 
1347, 1247, 1212, 1163, 1117, 1086, 968, 944, 894, 827, 765, 743, 724 cm-1; HRMS (MM:ESI-
APCI+) m/z calc’d for C20H21N2O3 [M+H]+: 337.1547, found 337.1555. 
 
Preparation of N-Acyl Indoles 
 
General Procedure 1 
 
 
 
To an oven-dried vial containing α-aryl carboxylic acid (1.2 equiv) was added SOCl2 neat 
(2.4 equiv) and the resulting mixture stirred at 25 °C for 20 min then 70 °C for 2 h (note: effluent 
gas flow is bubbled through a glass tube packed with powdered NaOH).  The reaction was then 
concentrated in vacuo to afford the crude acid chloride, which was used in the next step without 
further purification. 
A flame-dried flask containing indole (1.0 equiv) in THF (500 mM) was cooled to 0 °C 
in an ice bath and n-BuLi (1.05 equiv) was added dropwise.  The mixture was stirred at 0 °C for 
15 min then cooled to –78 °C in a dry-ice acetone bath.  The crude acid chloride dissolved in 
THF is then added quickly, and the resulting mixture allowed to slowly warm to room 
temperature.  Then reaction was then quenched with water and extracted with Et2O.  The 
combined organic layers were dried over Na2SO4 and the desired N-acyl indole isolated by silica 
gel flash chromatography. 
 
 
1-(1H-indol-1-yl)-2-phenylbutan-1-one (SI1) 
Prepared according to general procedure 1.  Purified by column chromatography (3% Et2O in 
hexanes) to provide the desired product as a white solid (428.2 mg, 81% yield); 1H NMR (300 
MHz, CDCl3): δ 8.54 (d, J = 8.3, 1H), 7.51–7.42 (m, 2H), 7.38–7.13 (m, 7H), 6.48 (d, J = 3.8 
Hz, 1H), 4.10 (t, J = 7.2 Hz, 1H), 2.35–2.18 (m, 1H), 1.89 (dt, J = 13.7, 7.2 Hz, 1H), 0.93 (t, J = 
7.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ 171.9, 139.1, 136.0, 130.3, 129.1, 127.7, 127.5, 
HO
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R
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125.2, 124.9, 123.8, 120.8, 117.0, 109.1, 53.7, 27.9, 12.3;  IR (Neat Film, NaCl) 3063, 2967, 
2943, 2874, 1704, 1602, 1584, 1539, 1472, 1451, 1384, 1355, 1328, 1304, 1222, 1208, 1181, 
1154, 1082, 1017, 903, 880, 825, 807, 766, 749, 700 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d 
for C18H18NO [M+H]+: 264.1383, found 264.1377. 
 
 
1-(1H-indol-1-yl)-2-(p-tolyl)butan-1-one (SI2) 
Prepared according to general procedure 1.  Purified by column chromatography (3% Et2O in 
hexanes) to provide the desired product as a yellow oil (901.0 mg, 76% yield); 1H NMR (500 
MHz, CDCl3) δ 8.57 (dd, J = 8.4, 0.9 Hz, 1H), 7.53–7.46 (m, 2H), 7.35 (ddd, J = 8.5, 7.3, 1.3 
Hz, 1H), 7.27–7.22 (m, 3H), 7.16–7.09 (m, 2H), 6.52 (dd, J = 3.8, 0.8 Hz, 1H), 4.11 (t, J = 7.2 
Hz, 1H), 2.36–2.21 (m, 4H), 1.91 (dp, J = 13.7, 7.4 Hz, 1H), 0.97 (t, J = 7.4 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 172.0, 137.0, 136.1, 136.0, 130.3, 129.8, 127.5, 125.0, 124.9, 123.7, 120.7, 
116.9, 108.9, 53.3, 27.8, 21.0, 12.2; IR (Neat Film, NaCl) 3051, 3024, 2966, 2931, 2874, 1704, 
1584, 1539, 1514, 1472, 1451, 1384, 1355, 1325, 1304, 1223, 1208, 1187, 1155, 1084, 904, 808, 
785, 767, 751, 715 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H20NO [M+H]+: 278.1539, 
found 278.1531. 
 
 
1-(1H-indol-1-yl)-2-(4-methoxyphenyl)butan-1-one (SI3) 
Prepared according to general procedure 1.  Purified by column chromatography (3% Et2O in 
hexanes) to provide the desired product as a yellow oil containing minor impurities (1.2439 g, 
85% yield); 1H NMR (500 MHz, CDCl3) δ 8.56 (dq, J = 8.3, 0.9 Hz, 1H), 7.53–7.48 (m, 2H), 
7.35 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.30–7.22 (m, 3H), 6.89–6.82 (m, 2H), 6.53 (dd, J = 3.8, 0.7 
Hz, 1H), 4.10 (t, J = 7.3 Hz, 1H), 3.76 (s, 3H), 2.37–2.20 (m, 1H), 1.90 (m, 1H), 0.97 (t, J = 7.3 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 172.2, 158.9, 135.9, 131.1, 130.3, 128.7, 125.1, 124.9, 
123.7, 120.7, 116.9, 114.4, 108.9, 55.1, 52.8, 27.8, 12.2; IR (Neat Film, NaCl) 2964, 2933, 1702, 
1610, 1540, 1511, 1450, 1384, 1354, 1324, 1302, 1252, 1222, 1207, 1179, 1154, 1033, 904, 820, 
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788, 766, 752 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H20NO2 [M+H]+: 294.1489, 
found 294.1494. 
 
 
2-(3,4-dimethoxyphenyl)-1-(1H-indol-1-yl)butan-1-one (SI4) 
Prepared according to general procedure 1.  Purified by column chromatography (20 → 30% 
Et2O in hexanes) to provide the desired product as a yellow oil (838.3 mg, 62% yield); 1H NMR 
(500 MHz, CDCl3) δ 8.56 (dq, J = 8.3, 0.9 Hz, 1H), 7.54–7.49 (m, 2H), 7.35 (ddd, J = 8.4, 7.2, 
1.3 Hz, 1H), 7.29–7.22 (m, 1H), 6.92–6.85 (m, 2H), 6.81 (d, J = 8.1 Hz, 1H), 6.54 (dd, J = 3.8, 
0.8 Hz, 1H), 4.08 (t, J = 7.3 Hz, 1H), 3.86 (s, 3H), 3.84 (s, 3H), 2.28 (dt, J = 13.7, 7.3 Hz, 1H), 
1.92 (dt, J = 13.8, 7.3 Hz, 1H), 0.97 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 172.1, 
149.5, 148.4, 136.0, 131.6, 130.3, 125.2, 124.9, 123.8, 120.8, 120.2, 116.9, 111.5, 110.3, 109.1, 
56.0, 55.9, 53.4, 27.9, 12.3; IR (Neat Film, NaCl) 2964, 2934, 1699, 1591, 1516, 1451, 1355, 
1326, 1302, 1262, 1242, 1206, 1152, 1027, 790, 766, 752 cm-1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C20H22NO3 [M+H]+: 324.1594, found 324.1588. 
 
 
1-(5-methyl-1H-indol-1-yl)-2-phenylbutan-1-one (SI5) 
Prepared according to general procedure 1.  Purified by column chromatography (5% Et2O in 
hexanes) to provide the desired product as a cream-colored solid (567.3 mg, 82% yield); 1H 
NMR (500 MHz, CDCl3) δ 8.43 (d, J = 8.4 Hz, 1H), 7.45 (d, J = 3.7 Hz, 1H), 7.38–7.27 (m, 5H), 
7.28–7.20 (m, 1H), 7.17 (d, J = 8.4 Hz, 1H), 6.45 (d, J = 3.7 Hz, 1H), 4.14 (t, J = 7.2 Hz, 1H), 
2.43 (s, 3H), 2.31 (dtd, J = 14.7, 7.3, 1.0 Hz, 1H), 1.99–1.89 (m, 1H), 0.99 (td, J = 7.4, 0.9 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 171.7, 139.3, 134.2, 133.4, 130.6, 129.2, 127.8, 127.5, 
126.5, 124.9, 120.7, 116.6, 109.0, 53.7, 27.9, 21.5, 12.4; IR (Neat Film, NaCl) 3027, 2967, 2931, 
2874, 1703, 1582, 1541, 1468, 1382, 1328, 1304, 1208, 1182, 1089, 903, 833, 823, 811, 740, 700 
cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H20NO [M+H]+: 278.1539, found 278.1534. 
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1-(3-methyl-1H-pyrrol-1-yl)-2-(o-tolyl)butan-1-one (SI6) 
Prepared according to general procedure 1.  Purified by column chromatography (5% Et2O in 
hexanes) to provide the desired product as a light yellow oil (539.3 mg, 54% yield) Note: 
compound darkens in color overtime under argon at –20 °C; 1H NMR (500 MHz, CDCl3) δ 
7.27–6.92 (m, 6H), 6.03 (dd, J = 3.3, 1.6 Hz, 1H), 4.24 (dd, J = 8.5, 5.7 Hz, 1H), 2.47 (s, 3H), 
2.20 (ddq, J = 14.5, 8.5, 7.3 Hz, 1H), 2.00 (d, J = 1.2 Hz, 3H), 1.84–1.64 (m, 1H), 0.98 (t, J = 7.4 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 170.9, 137.9, 134.6, 131.0, 127.3, 127.0, 126.8, 123.8, 
119.3, 116.5, 115.4, 48.5, 27.4, 19.8, 12.7, 12.1; IR (Neat Film, NaCl) 3021, 2964, 2928, 2874, 
1708, 1488, 1459, 1396, 1355, 1327, 1306, 1192, 1171, 1082, 1066, 952, 905, 834, 820, 780, 
756, 730 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C16H20NO [M+H]+: 242.1539, found 
242.1532. 
 
 
2-(2-bromophenyl)-1-(3-methyl-1H-pyrrol-1-yl)butan-1-one (SI7) 
Prepared according to general procedure 1.  Purified by column chromatography (3% Et2O in 
hexanes) to provide the desired product as a yellow oil (1.56 g, 72% yield) Note: compound 
darkens in color overtime under argon at –20 °C; 1H NMR (500 MHz, CDCl3) δ 7.59 (dd, J = 
8.0, 1.3 Hz, 1H), 7.36 (dd, J = 7.8, 1.7 Hz, 1H), 7.28–7.22 (m, 2H), 7.11 (ddd, J = 8.0, 7.3, 1.7 
Hz, 2H), 6.07 (dd, J = 3.3, 1.6 Hz, 1H), 4.62 (dd, J = 8.2, 6.1 Hz, 1H), 2.16 (ddq, J = 13.7, 8.2, 
7.3 Hz, 1H), 2.03 (d, J = 1.2 Hz, 3H), 1.83 (dqd, J = 13.6, 7.4, 6.2 Hz, 1H), 1.00 (t, J = 7.3 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 170.2, 138.7, 133.2, 129.0, 128.4, 128.4, 124.1, 124.1, 
119.5, 116.6, 115.7, 50.7, 27.6, 12.3, 12.1; IR (Neat Film, NaCl) 2967, 2930, 2875, 1709, 1489, 
1471, 1440, 1398, 1356, 1328, 1306, 1200, 1180, 1067, 1020, 908, 830, 810, 749 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C15H17BrNO [M+H]+: 306.0488, found 306.0477. 
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General Procedure 2 
 
A flame-dried round bottom flask was charged with i-Pr2NH (367 µL, 2.60 mmol, 1.3 
equiv) and THF (18.0 mL). The solution was then cooled in a 0 ºC ice bath for 10 min and a 2.40 
M solution of n-BuLi (996 µL, 2.40 mmol, 1.2 equiv) was added dropwise. After stirring for 15 
min, the solution was cooled in a –78 ºC acetone/dry ice bath for 15 min, after which time a 
solution of acyl indole (498.6 mg, 2.00 mmol, 1.0 equiv) in THF (4.0 mL) was added dropwise 
over 5 min. After stirring at –78 ºC for 1 h, neat ethyl iodide (193 µL, 2.40 mmol, 1.2 equiv) was 
then added dropwise. The reaction mixture was allowed to slowly warm to 20 ºC, and then 
heated to 65 ºC and stirred for 16 h, after which time the reaction was quenched with the slow 
addition of 10 mL H2O. The mixture was then transferred to a separatory funnel and the layers 
were separated. The aqueous layer was extracted 3 x 10 mL Et2O and the combined organics 
were dried over Na2SO4, filtered, and concentrated. The desired N-acyl indole was isolated by 
silica gel flash chromatography. 
 
 
2-(4-chlorophenyl)-1-(1H-indol-1-yl)butan-1-one (SI8) 
Prepared according to General Procedure 2 with (539.5 mg, 2.00 mmol, 1.0 equiv) of acyl 
indole. Purified by column chromatography (5% Et2O in hexanes) to provide the desired product 
as a light yellow oil (373.8 mg, 63% yield); 1H NMR (500 MHz, CDCl3) δ 8.54 (dd, J = 8.4, 0.9 
Hz, 1H), 7.52 (dt, J = 7.7, 1.1 Hz, 1H), 7.44 (d, J = 3.8 Hz, 1H), 7.36 (ddd, J = 8.4, 7.2, 1.3 Hz, 
1H), 7.30 (s, 4H), 7.28–7.24 (m, 1H), 6.56 (dd, J = 3.9, 0.8 Hz, 1H), 4.13 (t, J = 7.3 Hz, 1H), 
2.29 (dt, J = 13.8, 7.3 Hz, 1H), 2.03–1.76 (m, 1H), 0.97 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 171.5, 137.6, 136.0, 133.5, 130.4, 129.4, 129.2, 125.4, 124.6, 124.0, 120.9, 117.0, 
109.5, 53.1, 27.9, 12.3; IR (Neat Film, NaCl) 2967, 2361, 1700, 1540, 1491, 1451, 1384, 1354, 
1328, 1302, 1221, 1207, 1094, 1015, 904, 814, 794, 752 cm-1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C18H17ClNO [M+H]+: 298.0993, found 298.0984. 
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2-(4-bromophenyl)-1-(1H-indol-1-yl)butan-1-one (SI9) 
Prepared according to General Procedure 2 with (628.4 mg, 2.00 mmol, 1.0 equiv) of acyl 
indole. Purified by column chromatography (5% Et2O in hexanes) to provide the desired product 
as a white solid (451.0 mg, 66% yield); 1H NMR (500 MHz, CDCl3) δ 8.54 (d, J = 8.3 Hz, 1H), 
7.52 (d, J = 7.7 Hz, 1H), 7.48–7.41 (m, 3H), 7.38–7.32 (m, 1H), 7.30–7.20 (m, 3H), 6.56 (d, J = 
3.8 Hz, 1H), 4.12 (t, J = 7.2 Hz, 1H), 2.29 (dp, J = 14.6, 7.3 Hz, 1H), 1.92 (dp, J = 14.6, 7.3 Hz, 
1H), 0.98 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 171.5, 138.1, 136.0, 132.3, 130.4, 
129.6, 125.4, 124.6, 124.0, 121.6, 120.9, 117.0, 109.5, 53.2, 27.9, 12.3; IR (Neat Film, NaCl) 
3052, 2967, 2931, 2874, 1703, 1486, 1451, 1383, 1354, 1327, 1301, 1207, 1154, 1074, 1011, 
904, 880, 812, 792, 755, 751, 713 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C18H17BrNO 
[M+H]+: 342.0488, found 342.0497. 	
 
2-(4-fluorophenyl)-1-(1H-indol-1-yl)butan-1-one (SI10) 
Prepared according to General Procedure 2 with (506.6 mg, 2.00 mmol, 1.0 equiv) of acyl 
indole. Purified by column chromatography (5% Et2O in hexanes) to provide the desired product 
as a white solid (360.4 mg, 64% yield); 1H NMR (500 MHz, CDCl3) δ 8.55 (d, J = 8.3 Hz, 1H), 
7.52 (dd, J = 7.7, 1.0 Hz, 1H), 7.46 (d, J = 3.8 Hz, 1H), 7.39–7.29 (m, 3H), 7.30–7.22 (m, 1H), 
7.07–6.97 (m, 2H), 6.56 (dd, J = 3.8, 0.6 Hz, 1H), 4.15 (t, J = 7.3 Hz, 1H), 2.30 (dt, J = 13.8, 7.3 
Hz, 1H), 1.92 (dq, J = 14.1, 7.3 Hz, 1H), 0.98 (t, J = 7.3 Hz, 3H); 19F NMR (282 MHz, CDCl3) δ 
–114.9 (tt, J = 8.5, 5.2 Hz); 13C NMR (100 MHz, CDCl3) δ 171.8, 162.1 (d, JC–F = 246.2 Hz), 
136.0, 134.8 (d, JC–F = 3.3 Hz), 130.3, 129.4 (d, JC–F = 8.0 Hz), 125.3, 124.7, 123.9, 120.9, 117.0, 
116.0 (d, JC–F = 21.5 Hz), 109.3, 52.8, 27.9, 12.2; IR (Neat Film, NaCl) 3074, 2967, 2934, 2873, 
1702, 1603, 1508, 1450, 1384, 1354, 1327, 1301, 1222, 1207, 1158, 818, 792, 752, 714 cm-1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C18H17FNO [M+H]+: 282.1289, found 282.1286. 
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1-(1H-indol-1-yl)-2-(4-(trifluoromethyl)phenyl)butan-1-one (SI11) 
Prepared according to General Procedure 2.  Purified by column chromatography (6% Et2O in 
hexanes) to provide the desired product as a white solid (190.8 mg, 58% yield); 1H NMR (500 
MHz, CDCl3) δ 8.55 (dd, J = 8.3, 0.9 Hz, 1H), 7.62–7.58 (m, 2H), 7.55–7.48 (m, 3H), 7.44 (d, J 
= 3.9 Hz, 1H), 7.37 (ddd, J = 8.5, 7.2, 1.3 Hz, 1H), 7.30–7.25 (m, 1H), 6.57 (dd, J = 3.8, 0.7 Hz, 
1H), 4.23 (t, J = 7.3 Hz, 1H), 2.41–2.26 (m, 1H), 1.95 (dt, J = 13.8, 7.3 Hz, 1H), 0.99 (t, J = 7.4 
Hz, 3H); 19F NMR (282 MHz, CDCl3) δ –62.6; 13C NMR (100 MHz, CDCl3) δ 171.2, 143.0 (d, J 
= 1.5 Hz), 136.0, 130.4, 129.9 (q, J = 32.6 Hz), 128.3, 126.1 (q, J = 3.8 Hz), 125.5, 125.4 (q, J = 
272.4 Hz), 124.5, 124.1, 121.0, 117.0, 109.7, 53.5, 28.0, 12.3; IR (Neat Film, NaCl) 1702, 1451, 
1384, 1354, 1324, 1304, 1208, 1166, 1123, 1068, 1068, 1018, 831, 800, 766, 752 cm-1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C19H17F3NO [M+H]+: 332.1257, found 332.1248. 
 
 
General Procedure 3  
 
 
A flame-dried round bottom flask was charged with i-Pr2NH (1.82 mL, 13.0 mmol, 1.3 
equiv) and THF (15 mL). The solution was then cooled in a 0 ºC ice bath for 10 min and a 2.40 
M solution of n-BuLi (5.0 mL, 12.0 mmol, 1.2 equiv) was added dropwise. After stirring for 15 
min, the solution was cooled in a –78 ºC acetone/dry ice bath for 15 min, after which time a 
solution of methyl phenyl acetate (1.41 mL, 10.0 mmol, 1.0 equiv) in THF (29 mL) was added 
dropwise over 10 min. After stirring at –78 ºC for 1 h, the appropriate electrophile (1.5 equiv) 
was then added neat dropwise. The reaction mixture was allowed to slowly warm to 20 ºC and 
stirred for 16 h after which time the reaction was quenched with the slow addition of 30 mL of 
N
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sat. aq. NH4Cl. The mixture was then transferred to a separatory funnel and the layers were 
separated. The aqueous layer was extracted 3 x 20 mL EtOAc and the combined organics were 
dried over Na2SO4, filtered, and concentrated.  
 The crude material was then transferred to a round bottom flask and dissolved in THF (28 
mL) and H2O (20 mL). To the solution was then added LiOH (479.0 mg, 20.0 mmol, 2.0 equiv) 
and the resulting reaction mixture was stirred at 20 ºC for 16 h. The mixture was then transferred 
to a separatory funnel and washed with 2 x 5 mL Et2O. The aqueous layer was then slowly 
acidified to pH 1 with 2.0 N HCl and extracted 2 x 10 mL Et2O. The combined organics were 
dried over Na2SO4, filtered, and concentrated. The crude acid was used in the next step without 
further purification.  
To an oven-dried flask containing α-aryl carboxylic acid (5.0 mmol, 1.0 equiv) was 
added SOCl2 neat (620 µL, 1.7 equiv) and the resulting mixture stirred at 25 °C for 20 min then 
70 °C for 2 h (note: effluent gas flow is bubbled through a glass tube packed with powdered 
NaOH). The reaction was then concentrated in vacuo to afford the crude acid chloride, which 
was used in the next step without further purification. 
A separate flame-dried flask containing freshly distilled indoline (4.20 mmol, 1.0 equiv), 
Et3N (1.17 mL, 8.40 mmol, 2.0 equiv), and DMAP (25.7 mg, 0.21 mmol, 0.05 equiv) in CH2Cl2 
(42 mL) was cooled to –10 °C in an acetone/ice bath and the crude acid chloride (5.0 mmol, 1.2 
equiv) dissolved in CH2Cl2 (21 mL) was added dropwise via cannula transfer.  The mixture was 
stirred at –10 °C for 15 min then warmed to 23 ºC and stirred for 18 h.  The reaction mixture was 
quenched with saturated NaHCO3 (20 mL) and transferred to a separatory funnel. The layers 
were separated and the aqueous layer was extracted twice with CH2Cl2 (20 mL). The combined 
organics were washed with brine (10 mL), dried over Na2SO4, filtered, and concentrated to 
afford the crude amide which was used in the next step without further purification. 
The crude amide prepared above was transferred to a round bottom flask affixed with a 
reflux condenser.  Dry toluene (42 mL) and DDQ (2,3-Dichloro-5,6-dicyano-1,4-benzoquinone) 
(1.14 g, 5.0 mmol, 1.2 equiv) were then added and the resulting dark red reaction solution was 
heated to reflux for 16 h. The crude reaction mixture was then filtered through a pad of celite 
with toluene, concentrated, and purified via flash column chromatography to afford the desired 
acyl indole. 
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1-(1H-indol-1-yl)-2-phenylheptan-1-one (SI12) 
Prepared according to General Procedure 3 with n-pentyl iodide (1.96 mL, 15.0 mmol, 1.5 
equiv). Purified by column chromatography (5% Et2O in hexanes) to provide the desired product 
as a colorless oil (319.5 mg, 25% yield);	1H NMR (500 MHz, CDCl3) δ 8.58 (dq, J = 8.4, 0.9 Hz, 
1H), 7.54–7.48 (m, 2H), 7.39–7.30 (m, 5H), 7.30–7.21 (m, 2H), 6.54 (dd, J = 3.8, 0.8 Hz, 1H), 
4.25 (t, J = 7.2 Hz, 1H), 2.34–2.25 (m, 1H), 1.90 (tdd, J = 12.9, 8.5, 5.7 Hz, 1H), 1.46–1.25 (m, 
6H), 0.91–0.84 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 172.0, 139.4, 136.0, 130.3, 129.2, 127.7, 
127.5, 125.2, 124.8, 123.8, 120.7, 117.0, 109.1, 52.1, 34.7, 31.8, 27.4, 22.6, 14.1; IR (Neat Film, 
NaCl) 3063, 3029, 2954, 2928, 2858, 1704, 1602, 1584, 1539, 1451, 1384, 1353, 1311, 1207, 
1154, 1102, 941, 919, 880, 766, 749, 700 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C21H24NO [M+H]+: 306.1846, found 306.1846. 
 
	
1-(1H-indol-1-yl)-2,3-diphenylpropan-1-one (SI13) 
Prepared according to General Procedure 3 with BnBr (1.78 mL, 15.0 mmol, 1.5 equiv). Purified 
by column chromatography (5% Et2O in hexanes) to provide the desired product as a white solid 
(830.7 mg, 61% yield); 1H NMR (500 MHz, CDCl3) δ 8.56 (dd, J = 8.3, 0.9 Hz, 1H), 7.48 (dt, J 
= 7.5, 0.9 Hz, 1H), 7.39 (d, J = 3.8 Hz, 1H), 7.34 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.32 – 7.27 (m, 
4H), 7.26 – 7.10 (m, 7H), 6.48 (dd, J = 3.9, 0.7 Hz, 1H), 4.51 (t, J = 7.2 Hz, 1H), 3.67 (dd, J = 
13.7, 7.6 Hz, 1H), 3.14 (dd, J = 13.8, 6.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 171.2, 139.1, 
138.7, 136.0, 130.3, 129.3, 129.2, 128.5, 127.8, 127.7, 126.6, 125.3, 124.8, 123.9, 120.8, 117.0, 
109.3, 54.4, 40.8; IR (Neat Film, NaCl) 3155, 3062, 3029, 2927, 1950, 1805, 1698, 1601, 1585, 
1539, 1495, 1472, 1453, 1385, 1354, 1319, 1300, 1221, 1207, 1108, 1074, 911, 898, 766, 749, 
699 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C23H20NO [M+H]+: 326.1539, found 
326.1536. 
N
O
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O
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1-(1H-indol-1-yl)-4-methyl-2-phenylpentan-1-one (SI14) 
Prepared according to General Procedure 3 with i-butyl iodide (1.73 mL, 15.0 mmol, 1.5 equiv). 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
white solid (1.2177 g, 99% yield); 1H NMR (500 MHz, CDCl3) δ 8.56 (d, J = 8.3 Hz, 1H), 7.54 
(d, J = 3.8 Hz, 1H), 7.52–7.50 (m, 1H), 7.39–7.29 (m, 5H), 7.27–7.22 (m, 2H), 6.55 (dd, J = 3.8, 
0.7 Hz, 1H), 4.37 (t, J = 7.3 Hz, 1H), 2.22 (dt, J = 13.6 Hz, 7.4 Hz, 1H), 1.79 (dt, J = 13.7, 6.9 
Hz, 1H), 1.61 (dp, J = 13.5, 6.8 Hz, 1H), 0.97 (dd, J = 27.5, 6.6 Hz, 6H); 13C NMR (100 MHz, 
CDCl3) δ 172.0, 139.5, 136.1, 130.4, 129.3, 127.8, 127.5, 125.3, 124.8, 123.9, 120.9, 117.1, 
109.3, 49.8, 43.8, 25.9, 22.9, 22.7; IR (Neat Film, NaCl) 3386, 3154, 3063, 3029, 2956, 2868, 
1703, 1602, 1585 1538, 1493, 1471, 1451, 1385, 1344, 1332, 1308, 1295, 1222, 1207, 1103, 
1084, 1018, 943, 886, 766, 748, 670 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C20H22NO 
[M+H]+: 292.1696, found 292.1696. 
 
1-(5-bromo-1H-indol-1-yl)-2-phenylbutan-1-one (SI15) 
To a flame-dried conical flask containing α-aryl carboxylic acid (1 equiv) was added SOCl2 neat 
(2 equiv) and the resulting mixture stirred at 25 °C for 20 min then 70 °C for 2 h (note: effluent 
gas flow is bubbled through a glass tube packed with powdered NaOH).  The reaction was then 
concentrated in vacuo to afford the crude acid chloride, which was used in the next step without 
further purification. 
To a flame-dried 25 mL round bottom flask was added 5-bromoindole (588.1 mg, 3.00 mmol, 
1.0 equiv), DMAP (36.7 mg, 0.30 mmol, 0.10 equiv), CH2Cl2 (5.0 mL), and Et3N (627 µL, 4.50 
mmol, 1.5 equiv). The resulting clear, colorless solution was then cooled in a 0 ºC ice bath for 10 
min before a solution of the above crude acid chloride in CH2Cl2 (3.0 mL) was added dropwise 
via cannula. The resulting bright yellow solution was stirred at 23 ºC for 18 h then concentrated 
under reduced pressure. The crude yellow oil was then dissolved in Et2O (10 mL), transferred to 
N
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O
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a separatory funnel, and washed with H2O (20 mL). The aqueous layer was then extracted with 
Et2O (3 x 10 mL). The combined organics were then washed with brine (10 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure to afford an orange oil which was 
purified by column chromatography (3% Et2O in hexanes) to provide the desired product as an 
off white solid with minor impurities (654.3 mg, 64% yield); 1H NMR (400 MHz, CDCl3) δ 8.44 
(d, J = 8.8 Hz, 1H), 7.63 (d, J = 1.9 Hz, 1H), 7.49 (d, J = 3.8 Hz, 1H), 7.44 (dd, J = 8.8, 2.0 Hz, 
1H), 7.38–7.30 (m, 4H), 7.30–7.22 (m, 1H), 6.46 (d, J = 3.8 Hz, 1H), 4.12 (t, J = 7.2 Hz, 1H), 
2.30 (dt, J = 14.1, 7.3 Hz, 1H), 1.95 (dt, J = 14.1, 7.01 Hz, 1H), 0.98 (t, J = 7.3, 3H); 13C NMR 
(100 MHz, CDCl3) δ 171.8, 138.8, 134.6, 132.0, 129.2, 127.9, 127.7, 127.6, 125.9, 123.4, 118.3, 
117.0, 108.2, 53.7, 27.8, 12.3; IR (Neat Film, NaCl) 3063, 3028, 2967, 2932, 2874, 1704, 1575, 
1534, 1444, 1377, 1325, 1304, 1217, 1199, 1181, 1088, 896, 826, 810, 699 cm-1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C18H17BrNO [M+H]+: 342.0488, found 342.0478. 
Derivatization of Alkylation Products 
 
 
(R)-2-ethyl-2-phenylpent-4-enoic acid (3) 
To a flame-dried round bottom flask containing a stirred suspension of KOTMS (162 mg, 1.26 
mmol) in THF (1.5 mL) was added a solution of acyl indole 2a (38.2 mg, 0.126 mmol) in THF 
(1.5 mL).  The resulting mixture was placed in a 60 °C oil bath and stirred for 16 h.  The crude 
reaction was diluted with Et2O and 5 M NaOH, and the layers separated.  The aqueous layer was 
washed with Et2O and acidified with 4 M HCl to pH 1.  The aqueous layer was extracted with 
Et2O three times and the combined organic layers washed with water, dried over MgSO4, and 
concentrated to a light yellow solid (25.6 mg, 99% yield), [α]D25 –30.9 (c 1.0, CHCl3); 1H NMR 
(300 MHz, CDCl3) δ 7.45–7.17 (m, 5H), 5.54 (dddd, J = 17.0, 10.1, 7.6, 6.8 Hz, 1H), 5.16–4.96 
(m, 2H), 2.81 (qdt, J = 14.1, 6.8, 1.2 Hz, 2H), 2.22–1.90 (m, 2H), 0.81 (t, J = 7.4 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 181.9, 141.5, 133.5, 128.5, 127.1, 126.8, 118.5, 54.0, 38.4, 26.9, 8.5; 
IR (Neat Film, NaCl) 3064, 2975, 1699, 1498, 1447, 1401, 1252, 918, 698 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C13H17O2 [M+H]+: 205.1223, found 205.1213. 
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ethyl (R)-2-ethyl-2-phenylpent-4-enoate (4) 
To a flame-dried round bottom flask containing a stirred solution of KOEt (32.2 mg, 0.383 
mmol) in THF (1.5 mL) was added a solution of acyl indole 2a (38.7 mg, 0.128 mmol) and the 
resulting mixture stirred at 25 °C for 15 h.  The crude reaction was diluted with Et2O and 
quenched with saturated NH4Cl, and the layers separated.  The aqueous layer was extracted with 
Et2O and the combined organic fractions dried over Na2SO4 and concentrated. The crude product 
was purified by silica gel flash chromatography (5% Et2O in hexanes) to provide the desired 
product as a colorless oil (22.3 mg, 75% yield), [α]D25 –4.7 (c 1.0, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.33–7.07 (m, 5H), 5.46 (dddd, J = 16.9, 10.1, 7.8, 6.7 Hz, 1H), 5.07–4.87 (m, 2H), 
4.08 (q, J = 7.1 Hz, 2H), 2.87–2.58 (m, 2H), 2.13–1.87 (m, 2H), 1.12 (t, J = 7.1 Hz, 3H), 0.71 (t, 
J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 175.6, 142.4, 133.8, 128.3, 126.7, 126.6, 118.2, 
60.8, 54.1, 38.7, 27.1, 14.2, 8.5; IR (Neat Film, NaCl) 2976, 2360, 1728, 1220, 1135, 1030, 916, 
700 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C15H21O2 [M+H]+: 233.1536, found 
233.1531. 
 
 
(R)-2-ethyl-2-phenylpent-4-en-1-ol (5) 
To a flame-dried round bottom flask was added acyl indole 2a (32.6 mg, 0.107 mmol, 1.0 equiv) 
and THF (2.1 mL). The resulting solution was cooled to 0 ºC for 5 min and then a 1.0 M solution 
of LiAlH4 (320 mL, 0.320 mmol, 3.0 equiv) was added dropwise. The resulting solution was 
stirred at 0 ºC for 5 min, then diluted with Et2O (2.1 mL) and quenched with the addition of H2O 
(12 µL) followed by 15% w/v NaOH/H2O (12 µL), and an additional portion of H2O (36 µL). 
The resulting gray suspension was warmed to 20 ºC and stirred vigorously for 15 min. MgSO4 
(50 mg) was added and the resulting suspension was stirred for 15 min and filtered through a 
plug of celite with Et2O. The crude product was purified by silica gel flash chromatography 
N
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EtO
Et
KOEt
THF, 25 ºC
O
N
O
Et
HO
Et
LiAlH4
THF, 0 ºC
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(10% Et2O in hexanes) to provide the desired product as a colorless oil (17.2 mg, 84% yield); 
[α]D25  +12.9 (c 0.65, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.38–7.31 (m, 4H), 7.23 (td, J = 
6.4, 2.3 Hz, 1H), 5.70 (ddt, J = 17.3, 10.1, 7.3 Hz, 1H), 5.18–5.01 (m, 2H), 3.82–3.70 (m, 2H), 
2.55 (ddd, J = 61.6, 13.9, 7.2 Hz, 2H), 1.73 (q, J = 7.4 Hz, 2H), 1.34 (s, 1H), 0.74 (t, J = 7.4 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 143.9, 134.9, 128.6, 127.0, 126.3, 117.8, 67.9, 46.3, 38.6, 
27.5, 8.0; IR (Neat Film, NaCl) 3399 (br), 3060, 3024, 3004, 2966, 2934, 2880, 2361, 1638, 
1497, 1459, 1456, 1379, 1045, 1001, 914, 760, 699 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d 
for C13H22NO [M+NH4]+: 208.1696, found 208.1692. 
 
 
(R)-2-ethyl-1-(1H-indol-1-yl)-2-phenylpentane-1,4-dione (6) 
To a round bottom flask containing acyl indole 2a (33.1 mg, 0.109 mmol, 1.0 equiv) dissolved in 
2.5 mL of 9:1 DMF/H2O was added PdCl2 (5.8 mg, 0.033 mmol, 0.30 equiv) and CuCl (21.6 mg, 
0.218 mmol, 2.0 equiv). The flask was then quickly evacuated and backfilled three times with a 
balloon of O2, and then stirred at 20 ºC under a balloon of O2 for 48 h. The crude reaction was 
then diluted with EtOAc (2 mL) followed by brine (2 mL). The layers were separated and the 
aqueous layer was extracted with EtOAc (5 mL) twice. The combined organic layers were dried 
over Na2SO4, filtered, and concentrated. The crude product was purified by silica gel flash 
chromatography (10% Et2O in hexanes) to afford the desired product as a white foam in a 5:1 
ketone/aldehyde ratio (33.2 mg, 0.104 mmol, 95% yield); [α]D25 –198.3 (c 1.45, CHCl3); [α]D25 –
194.5 (c 0.58, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.48 (d, J = 8.4 Hz, 1H), 7.37 (d, J = 7.7 
Hz, 1H), 7.31–7.23 (m , 5H), 7.23–7.12 (m, 2H), 6.70 (d, J = 3.9 Hz, 1H), 6.18 (d, J = 3.8 Hz, 
1H), 3.26 (d, J = 15.4 Hz, 1H), 3.14 (d, J = 15.5 Hz, 1H), 2.64 (dq, J = 14.9, 7.5 Hz, 1H), 2.32–
2.15 (m, 1H), 1.68 (s, 3H), 0.78 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 207.1, 173.5, 
142.1, 136.5, 129.3, 127.7, 126.5, 125.7, 125.2, 123.8, 120.5, 117.1, 108.4, 108.4, 55.8, 48.5, 
32.1, 27.5, 8.9; IR (Neat Film, NaCl) 3163, 3056, 3056, 2972, 1721, 1697, 1537, 1450, 1308, 
1206, 1076, 882, 768, 752, 702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H22NO2 
[M+H]+: 320.1645, found 320.1630. 
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Challenging Substrate Classes 
 
Figure S1. Selective enolization of esters and attempted palladium-catalyzed allylic alkylation. 
 
Figure S2. Poor enolization selectivity observed for ortho-substituted α−aryl substrates. 
Ligand Synthesis 
 
Bis(3-fluoro-4-(trifluoromethyl)phenyl)phosphine oxide (SI16) 
According to the procedure of Stoltz2; A flame-dried 50 mL round bottomed flask was charged 
with magnesium turnings (804.7 mg, 33.1 mmol, 3.1 equiv) and Et2O (17.8 mL). The mixture 
was cooled to 0 ºC and 4-bromo-2-fluoro-1-(trifluoromethyl)benzene (4.52 mL, 32.0 mmol, 3.0 
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equiv) was added dropwise over 15 min during which the reaction mixture turned from colorless 
to brown to black. A reflux condenser was then attached to the flask, and the mixture was 
warmed to 30 ºC in a water bath and stirred for 1 h. The resulting black solution was then canula 
transferred to a second 50 mL flame-dried round bottom flask to remove residual magnesium 
turnings. The resulting solution was then cooled to 0 ºC and neat diethyl phosphite (1.38 mL, 
10.7 mmol, 1.0 equiv) was added dropwise over 10 min. The black reaction mixture was then 
allowed to warm to 20 ºC over 1 h and stirred for 24 h. The reaction mixture was then cooled to 
0 ºC and 2.0 N HCl (20 mL) was added dropwise with vigorous stirring, leading to the 
precipitation of a brown solid. The mixture was then allowed to warm to 20 ºC and extracted 
with EtOAc (3 x 10 mL). The combined organic layers were then washed with brine (10 mL), 
dried over Na2SO4, filtered, and concentrated to an orange oil. Purification by silica gel 
chromatography (30% EtOAc in hexanes à 60% EtOAc in hexanes) provided the desired 
product as a yellow solid (2.6803 g, 7.72 mmol, 72% yield); 1H NMR (400 MHz, CDCl3) δ 8.78 
(s, 1H), 7.80 (td, J = 7.2, 3.2 Hz, 2H), 7.59 (ddd, J = 19.8, 13.7, 8.6 Hz, 4H); 19F NMR (282 
MHz, CDCl3) δ –62.02 (d, J = 12.7 Hz), –110.40 – –110.63 (m); 31P NMR (162 MHz, CDCl3) δ 
14.77; 13C NMR (100 MHz, CDCl3) δ 159.9 (dd, J = 262.9, 17.6 Hz), 137.2 (dd, J = 98.7, 6.0 
Hz), 128.7 (dq, J = 14.0, 4.4 Hz), 126.3 (dd, J = 11.1, 4.4 Hz), 123.7–122.4 (m), 121.8 (q, J = 
273.2 Hz), 119.2 (dd, J = 22.0, 12.5 Hz); IR (Neat Film, NaCl) 3040, 2368, 1622, 1576, 1498, 
1409, 1323, 1239, 1178, 1134, 1043, 951, 901, 833, 696, 632 cm–1; HRMS (MM:ESI-APCI+) 
m/z calc’d for C14H8F8OP [M+H]+: 375.0180, found 375.0172. 
 
(S)-(2-(4-(tert-butyl)-4,5-dihydrooxazol-2-yl)-4-(trifluoromethyl)phenyl)bis(3-fluoro-4-
(trifluoromethyl)phenyl)phosphine oxide (SI17) 
To a flame-dried 100 mL two-necked round bottom flask equipped with a reflux condenser and 
glass stopper was added phosphine oxide SI16 (2.4321 g, 6.50 mmol, 1.3 equiv), CuI (952.3 mg, 
5.00 mmol, 1.0 equiv), and toluene (11.4 mL) followed by N,N’-dimethylethylenediamine (1.61 
mL, 15.0 mmol, 3.0 equiv). The resulting green solution was stirred at 20 ºC for 20 min after 
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which time oxazoline (1.75 g, 5.00 mmol, 1.0 equiv), Cs2CO3 (6.03 g, 18.5 mmol, 3.7 equiv), 
and toluene (4.9 mL) were added. The flask was then immersed in a 110 ºC oil bath and the 
reaction suspension gradually turned blue and then orange. After 13 h, the reaction was cooled to 
20 ºC and the orange reaction mixture was loaded directly onto a silica gel column (hexanes à 
25% EtOAc in hexanes) to provide a white foam (841.9 mg, 26% yield); [α]D25 –47.5 (c 1.0, 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.24 (dd, J = 3.9, 1.8 Hz, 1H), 8.13–8.01 (m, 1H), 7.91–
7.87 (m, 1H), 7.80–7.60 (m, 4H), 7.50–7.39 (m, 2H), 4.03 – 3.93 (m, 2H), 3.42 (dd, J = 10.2, 9.4 
Hz, 1H), 0.72 (s, 9H); 31P NMR (121 MHz, CDCl3) δ 26.10; 19F NMR (282 MHz, CDCl3) δ –
61.90 (dd, J = 15.3, 12.6 Hz), –63.48, –111.76 – –112.14 (m); 13C NMR (100 MHz, CDCl3) δ 
160.8 (d, J = 17.3 Hz), 160.4 (d, J = 2.1 Hz), 158.2 (d, J = 17.3 Hz), 140.7 (d, J = 5.7 Hz), 139.8 
– 139.2 (m), 138.4 (d, J = 6.1 Hz), 136.2 (d, J = 10.3 Hz), 135.8 – 134.4 (m), 134.0, 133.0, 132.8 
(d, J = 6.6 Hz), 127.7 (ddt, J = 20.1, 9.0, 4.2 Hz), 126.8 (dd, J = 9.5, 4.2 Hz), 124.4, 123.4, 122.4 
– 121.3 (m), 120.9 – 120.3 (m), 119.9 (dd, J = 22.1, 11.1 Hz), 69.3, 33.6, 25.8s; IR (Neat Film, 
NaCl) 2963, 2907, 2873, 1664, 1621, 1574, 1497, 1479, 1664, 1621, 1574, 1497, 1479, 1407, 
1322, 1235, 1178, 1136, 1178, 1083, 1042, 964, 915, 833, 720, 699, 629 cm–1; HRMS (MM:ESI-
APCI+) m/z calc’d for C28H22F11NO2P [M+H]+: 644.1207, found 644.1184. 
 
 
(S)-2-(2-(bis(3-fluoro-4-(trifluoromethyl)phenyl)phosphaneyl)-5-(trifluoromethyl)phenyl)-
4-(tert-butyl)-4,5-dihydrooxazole (L2, (S)-Ty-PHOX) 
To an oven-dried 25 mL schlenk tube was added phosphine oxide SI17 and Ph2SiH2 (1.49 mL, 
8.05 mmol, 7.0 equiv) . The schlenk tube was then sealed and heated in a 140 ºC oil bath behind 
a blast shield. After 16 h, the reaction was cooled to 20 ºC and slowly opened to a nitrogen 
atmosphere.  The colorless reaction mixture was then loaded directly onto a silica gel column 
(hexanes à 25% CH2Cl2 in hexanes) to provide a white foam (610 mg, 85% yield); [α]D25 –12.5 
(c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.31–8.25 (m, 1H), 7.67–7.54 (m, 3H), 7.10 (dt, J 
= 19.3, 7.4 Hz, 2H), 7.03–6.95 (m, 3H), 4.33 (dd, J = 10.1, 8.7 Hz, 1H), 4.16 (t, J = 8.6 Hz, 1H), 
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3.99 (dd, J = 10.1, 8.5 Hz, 1H), 0.74 (s, 9H); 19F NMR (282 Hz, CDCl3) δ –61.51 (dd, J = 21.1, 
12.4 Hz), –63.10, –113.31 – –113.52 (m), –113.57 – –113.78 (m); 31P NMR (121 MHz, CDCl3) 
δ –7.38; 13C NMR (100 MHz, CDCl3) δ 161.05 – 160.82 (m), 160.49 (d, J = 4.0 Hz), 158.46 – 
158.25 (m), 145.63 (t, J = 4.2 Hz), 145.46 (d, J = 5.6 Hz), 140.49 (d, J = 28.6 Hz), 134.94, 
134.74 – 134.58 (m), 134.47 – 134.20 (m), 132.38 (d, J = 20.4 Hz), 131.64 (q, J = 33.3 Hz), 
129.24 (ddd, J = 34.0, 22.2, 3.7 Hz), 128.00 – 127.58 (m), 127.33 (dq, J = 12.2, 4.1 Hz), 126.65 
(p, J = 3.4 Hz), 126.43, 124.79, 123.73, 122.44 – 120.79 (m), 119.75 – 118.09 (m), 68.83, 33.59, 
25.60; IR (Neat Film, NaCl) 3071, 2960, 2871, 2138, 1655, 1617, 1570, 1491, 1430, 1403, 1323, 
1176, 1133, 1083, 1042, 967, 830, 735, 714, 698, 684, 624 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C28H22F11NOP [M+H]+: 628.1258, found 628.1271. 
 
 
X-Ray Crystal Structure for Allylated Product 2d (V18448) 
An X-ray quality crystal of allylation product 2d (compound V18448) was grown by slow 
evaporation of a solution in chloroform (approx. 30 mg/600 µL). Low-temperature diffraction 
data (φ-and ω-scans) were collected on a Bruker AXS D8 VENTURE KAPPA diffractometer 
coupled to a PHOTON II CPAD detector with Cu Kα radiation (λ = 1.54178 Å) from an IµS 
micro-source for the structure of compound V18448. The structure was solved by direct methods 
using SHELXS3 and refined against F2 on all data by full-matrix least squares with SHELXL-
20174 using established refinement techniques.5 All non-hydrogen atoms were refined 
anisotropically. All hydrogen atoms were included into the model at geometrically calculated 
positions and refined using a riding model. The isotropic displacement parameters of all 
hydrogen atoms were fixed to 1.2 times the U value of the atoms they are linked to (1.5 times for 
methyl groups). Compound V18448 crystallizes in the monoclinic space group P21 with one 
molecule in the asymmetric unit.  
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Figure S3. X-Ray Coordinate of Allylation Product 2d (compound V18448) 
 
Table 1.  Crystal data and structure refinement for V18448. 
Identification code  v18448 
Empirical formula  C26 H23 N O 
Formula weight  365.45 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 11.2225(10) Å a= 90°. 
 b = 6.4382(6) Å b= 99.6595(18)°. 
 c = 14.0893(13) Å g = 90°. 
Volume 1003.56(16) Å3 
Z 2 
Density (calculated) 1.209 Mg/m3 
Absorption coefficient 0.564 mm-1 
F(000) 388 
Crystal size 0.500 x 0.500 x 0.300 mm3 
Theta range for data collection 3.182 to 80.104°. 
Index ranges -14<=h<=14, -7<=k<=7, -17<=l<=17 
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Reflections collected 34321 
Independent reflections 4134 [R(int) = 0.0282] 
Completeness to theta = 67.679° 99.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.8766 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4134 / 1 / 253 
Goodness-of-fit on F2 1.038 
Final R indices [I>2sigma(I)] R1 = 0.0265, wR2 = 0.0681 
R indices (all data) R1 = 0.0265, wR2 = 0.0682 
Absolute structure parameter 0.05(4) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.201 and -0.133 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for V18448.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
______________________________________________________________________________  
 x y z U(eq) 
______________________________________________________________________________ 
O(1) 5786(1) 1813(2) 7273(1) 26(1) 
C(1) 5783(1) 3638(2) 7476(1) 17(1) 
C(2) 4688(1) 5066(2) 7141(1) 15(1) 
C(11) 4200(1) 5966(2) 8006(1) 17(1) 
C(12) 4150(1) 4711(3) 8806(1) 24(1) 
C(13) 3652(2) 5458(3) 9579(1) 35(1) 
C(14) 3193(2) 7449(3) 9561(1) 37(1) 
C(15) 3241(2) 8701(3) 8777(1) 34(1) 
C(16) 3742(1) 7973(2) 8000(1) 24(1) 
C(3) 3683(1) 3670(2) 6559(1) 18(1) 
C(21) 2520(1) 4803(2) 6183(1) 18(1) 
C(22) 1602(1) 4907(3) 6737(1) 24(1) 
C(23) 530(1) 5950(3) 6403(1) 29(1) 
C(24) 351(1) 6888(3) 5504(1) 30(1) 
C(25) 1252(1) 6781(3) 4941(1) 27(1) 
C(26) 2327(1) 5746(2) 5278(1) 21(1) 
C(4) 5090(1) 6761(2) 6474(1) 17(1) 
C(5) 5781(1) 5882(2) 5740(1) 22(1) 
C(6) 6953(2) 6153(3) 5768(1) 29(1) 
N(1) 6826(1) 4548(2) 7998(1) 17(1) 
C(31) 6936(1) 6510(2) 8438(1) 20(1) 
C(32) 8087(1) 6829(3) 8874(1) 23(1) 
C(33) 8774(1) 5024(2) 8712(1) 21(1) 
C(34) 9996(1) 4507(3) 8984(1) 27(1) 
C(35) 10389(1) 2616(3) 8694(1) 31(1) 
C(36) 9598(1) 1254(3) 8132(1) 31(1) 
C(37) 8379(1) 1719(3) 7857(1) 24(1) 
C(38) 7982(1) 3609(2) 8164(1) 18(1) 
______________________________________________________________________________
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Table 3.   Bond lengths [Å] and angles [°] for  V18448. 
_____________________________________________________  
O(1)-C(1)  1.2093(19) 
C(1)-N(1)  1.4021(17) 
C(1)-C(2)  1.5434(18) 
C(2)-C(11)  1.5317(17) 
C(2)-C(4)  1.5553(17) 
C(2)-C(3)  1.5630(18) 
C(11)-C(16)  1.390(2) 
C(11)-C(12)  1.3950(19) 
C(12)-C(13)  1.391(2) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.380(3) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.375(3) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.393(2) 
C(15)-H(15)  0.9500 
C(16)-H(16)  0.9500 
C(3)-C(21)  1.5111(18) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(21)-C(22)  1.3949(19) 
C(21)-C(26)  1.3967(19) 
C(22)-C(23)  1.388(2) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.387(2) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.388(2) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.390(2) 
C(25)-H(25)  0.9500 
C(26)-H(26)  0.9500 
C(4)-C(5)  1.5041(18) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
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C(5)-C(6)  1.320(2) 
C(5)-H(5)  0.9500 
C(6)-H(6A)  0.9500 
C(6)-H(6B)  0.9500 
N(1)-C(31)  1.4035(18) 
N(1)-C(38)  1.4145(17) 
C(31)-C(32)  1.3505(19) 
C(31)-H(31)  0.9500 
C(32)-C(33)  1.433(2) 
C(32)-H(32)  0.9500 
C(33)-C(34)  1.4006(19) 
C(33)-C(38)  1.410(2) 
C(34)-C(35)  1.380(3) 
C(34)-H(34)  0.9500 
C(35)-C(36)  1.395(3) 
C(35)-H(35)  0.9500 
C(36)-C(37)  1.391(2) 
C(36)-H(36)  0.9500 
C(37)-C(38)  1.390(2) 
C(37)-H(37)  0.9500 
 
O(1)-C(1)-N(1) 119.69(12) 
O(1)-C(1)-C(2) 122.66(12) 
N(1)-C(1)-C(2) 117.58(12) 
C(11)-C(2)-C(1) 110.77(10) 
C(11)-C(2)-C(4) 113.19(11) 
C(1)-C(2)-C(4) 107.86(10) 
C(11)-C(2)-C(3) 108.16(10) 
C(1)-C(2)-C(3) 106.58(11) 
C(4)-C(2)-C(3) 110.09(10) 
C(16)-C(11)-C(12) 118.57(13) 
C(16)-C(11)-C(2) 121.87(12) 
C(12)-C(11)-C(2) 119.46(13) 
C(13)-C(12)-C(11) 120.54(16) 
C(13)-C(12)-H(12) 119.7 
C(11)-C(12)-H(12) 119.7 
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C(14)-C(13)-C(12) 120.31(16) 
C(14)-C(13)-H(13) 119.8 
C(12)-C(13)-H(13) 119.8 
C(15)-C(14)-C(13) 119.60(15) 
C(15)-C(14)-H(14) 120.2 
C(13)-C(14)-H(14) 120.2 
C(14)-C(15)-C(16) 120.62(17) 
C(14)-C(15)-H(15) 119.7 
C(16)-C(15)-H(15) 119.7 
C(11)-C(16)-C(15) 120.36(15) 
C(11)-C(16)-H(16) 119.8 
C(15)-C(16)-H(16) 119.8 
C(21)-C(3)-C(2) 114.28(11) 
C(21)-C(3)-H(3A) 108.7 
C(2)-C(3)-H(3A) 108.7 
C(21)-C(3)-H(3B) 108.7 
C(2)-C(3)-H(3B) 108.7 
H(3A)-C(3)-H(3B) 107.6 
C(22)-C(21)-C(26) 118.29(13) 
C(22)-C(21)-C(3) 120.20(12) 
C(26)-C(21)-C(3) 121.50(12) 
C(23)-C(22)-C(21) 120.85(14) 
C(23)-C(22)-H(22) 119.6 
C(21)-C(22)-H(22) 119.6 
C(24)-C(23)-C(22) 120.35(14) 
C(24)-C(23)-H(23) 119.8 
C(22)-C(23)-H(23) 119.8 
C(23)-C(24)-C(25) 119.44(14) 
C(23)-C(24)-H(24) 120.3 
C(25)-C(24)-H(24) 120.3 
C(24)-C(25)-C(26) 120.22(14) 
C(24)-C(25)-H(25) 119.9 
C(26)-C(25)-H(25) 119.9 
C(25)-C(26)-C(21) 120.85(13) 
C(25)-C(26)-H(26) 119.6 
C(21)-C(26)-H(26) 119.6 
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C(5)-C(4)-C(2) 112.72(12) 
C(5)-C(4)-H(4A) 109.0 
C(2)-C(4)-H(4A) 109.0 
C(5)-C(4)-H(4B) 109.0 
C(2)-C(4)-H(4B) 109.0 
H(4A)-C(4)-H(4B) 107.8 
C(6)-C(5)-C(4) 123.74(14) 
C(6)-C(5)-H(5) 118.1 
C(4)-C(5)-H(5) 118.1 
C(5)-C(6)-H(6A) 120.0 
C(5)-C(6)-H(6B) 120.0 
H(6A)-C(6)-H(6B) 120.0 
C(1)-N(1)-C(31) 127.69(12) 
C(1)-N(1)-C(38) 124.72(12) 
C(31)-N(1)-C(38) 107.59(11) 
C(32)-C(31)-N(1) 110.11(13) 
C(32)-C(31)-H(31) 124.9 
N(1)-C(31)-H(31) 124.9 
C(31)-C(32)-C(33) 107.67(13) 
C(31)-C(32)-H(32) 126.2 
C(33)-C(32)-H(32) 126.2 
C(34)-C(33)-C(38) 119.61(15) 
C(34)-C(33)-C(32) 132.62(15) 
C(38)-C(33)-C(32) 107.76(12) 
C(35)-C(34)-C(33) 118.44(15) 
C(35)-C(34)-H(34) 120.8 
C(33)-C(34)-H(34) 120.8 
C(34)-C(35)-C(36) 121.20(14) 
C(34)-C(35)-H(35) 119.4 
C(36)-C(35)-H(35) 119.4 
C(37)-C(36)-C(35) 121.68(16) 
C(37)-C(36)-H(36) 119.2 
C(35)-C(36)-H(36) 119.2 
C(38)-C(37)-C(36) 116.98(15) 
C(38)-C(37)-H(37) 121.5 
C(36)-C(37)-H(37) 121.5 
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C(37)-C(38)-C(33) 122.06(13) 
C(37)-C(38)-N(1) 131.03(13) 
C(33)-C(38)-N(1) 106.87(12) 
_____________________________________________________________  
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Table 4.   Anisotropic displacement parameters  (Å2x 103) for V18448.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 23(1)  15(1) 39(1)  -3(1) -1(1)  2(1) 
C(1) 18(1)  16(1) 18(1)  1(1) 3(1)  -1(1) 
C(2) 16(1)  14(1) 16(1)  0(1) 2(1)  1(1) 
C(11) 14(1)  20(1) 16(1)  -2(1) 2(1)  -3(1) 
C(12) 21(1)  31(1) 21(1)  4(1) 3(1)  -2(1) 
C(13) 27(1)  59(1) 19(1)  1(1) 6(1)  -9(1) 
C(14) 26(1)  60(1) 27(1)  -19(1) 13(1)  -9(1) 
C(15) 28(1)  34(1) 43(1)  -17(1) 15(1)  -2(1) 
C(16) 24(1)  23(1) 28(1)  -4(1) 8(1)  0(1) 
C(3) 18(1)  17(1) 20(1)  -1(1) 1(1)  -1(1) 
C(21) 16(1)  15(1) 22(1)  -2(1) 1(1)  -2(1) 
C(22) 20(1)  28(1) 24(1)  -2(1) 2(1)  -5(1) 
C(23) 18(1)  32(1) 37(1)  -7(1) 7(1)  -2(1) 
C(24) 17(1)  25(1) 46(1)  -1(1) -2(1)  2(1) 
C(25) 23(1)  23(1) 32(1)  6(1) -3(1)  -2(1) 
C(26) 18(1)  22(1) 24(1)  0(1) 1(1)  -3(1) 
C(4) 18(1)  16(1) 17(1)  2(1) 3(1)  0(1) 
C(5) 28(1)  22(1) 19(1)  1(1) 7(1)  0(1) 
C(6) 30(1)  33(1) 28(1)  8(1) 13(1)  7(1) 
N(1) 16(1)  15(1) 19(1)  1(1) 2(1)  1(1) 
C(31) 20(1)  18(1) 20(1)  -2(1) 1(1)  0(1) 
C(32) 22(1)  24(1) 21(1)  -1(1) 0(1)  -3(1) 
C(33) 19(1)  27(1) 17(1)  4(1) 3(1)  -2(1) 
C(34) 17(1)  40(1) 24(1)  6(1) 1(1)  0(1) 
C(35) 17(1)  44(1) 31(1)  10(1) 5(1)  7(1) 
C(36) 26(1)  33(1) 34(1)  7(1) 10(1)  11(1) 
C(37) 23(1)  24(1) 27(1)  3(1) 6(1)  4(1) 
C(38) 15(1)  22(1) 17(1)  6(1) 4(1)  1(1) 
______________________________________________________________________________ 
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Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for V18448. 
______________________________________________________________________________
 x  y  z  U(eq) 
______________________________________________________________________________  
  
H(12) 4458 3335 8822 29 
H(13) 3627 4594 10122 42 
H(14) 2846 7953 10087 45 
H(15) 2929 10074 8765 41 
H(16) 3771 8853 7463 29 
H(3A) 3999 3053 6008 22 
H(3B) 3503 2516 6978 22 
H(22) 1710 4257 7351 29 
H(23) -83 6021 6792 34 
H(24) -384 7599 5275 36 
H(25) 1134 7416 4324 32 
H(26) 2939 5680 4887 26 
H(4A) 4365 7493 6137 20 
H(4B) 5602 7793 6874 20 
H(5) 5351 5085 5227 27 
H(6A) 7407 6943 6273 35 
H(6B) 7341 5559 5284 35 
H(31) 6293 7474 8431 24 
H(32) 8389 8032 9225 27 
H(34) 10541 5436 9358 33 
H(35) 11213 2235 8880 37 
H(36) 9901 -24 7933 37 
H(37) 7842 786 7476 29 
______________________________________________________________________________
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